https://www.mesothelioma-line.com/cd40-agonist-antibodies-in-cancer-immunotherapy/ 2019-08-26T15:06:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/meningeal-metastasis-of-a-malignant-peritoneal-mesothelioma-a-case-report-and-literature-review/ 2019-08-26T15:23:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/exosomal-mir-16-5p-as-a-target-for-malignant-mesothelioma/ 2019-08-26T16:34:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-the-c-terminus-of-galectin-9-induces-mesothelioma-apoptosis-and-m2-macrophage-depletion/ 2019-08-26T16:47:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesotip-phase-ii-multicenter-randomized-trial-evaluating-the-association-of-pipac-and-systemic-chemotherapy-vs-systemic-chemotherapy-alone-as-1st-line-treatment-of-malignant-peritoneal-mesothelioma/ 2019-08-26T17:03:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/pifithrin-%ce%bc-induces-necroptosis-through-oxidative-mitochondrial-damage-but-accompanies-epithelial-mesenchymal-transition-like-phenomenon-in-malignant-mesothelioma-cells-under-lactic-acidosis/ 2019-09-03T13:56:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/largely-unchanged-annual-incidence-and-overall-survival-of-pleural-mesothelioma-in-the-usa/ 2019-09-03T15:17:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/multi-antigen-vaccination-with-simultaneous-engagement-of-the-ox40-receptor-delays-malignant-mesothelioma-growth-and-increases-survival-in-animal-models/ 2019-09-03T16:02:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/phenotypic-and-functional-analysis-of-malignant-mesothelioma-tumor-infiltrating-lymphocytes/ 2019-09-03T16:24:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/multidisciplinary-palliative-treatment-including-isolated-thoracic-perfusion-for-progressive-malignant-pleural-mesothelioma-a-retrospective-observational-study/ 2019-09-09T14:24:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/curcumin-c3-complex-bioperine-has-antineoplastic-activity-in-mesothelioma-an-in-vitro-and-in-vivo-analysis/ 2019-09-09T15:16:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinicopathologic-study-of-deciduoid-mesothelioma-using-smarcb1-ini1-immunohistochemistry-and-fluorescence-in-situ-hybridization/ 2019-09-09T15:33:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/analysis-of-ccdc6-as-a-novel-biomarker-for-the-clinical-use-of-parp1-inhibitors-in-malignant-pleural-mesothelioma/ 2019-09-09T15:54:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/building-a-bridge-between-chemotherapy-and-immunotherapy-in-malignant-pleural-mesothelioma-investigating-the-effect-of-chemotherapy-on-immune-checkpoint-expression/ 2019-09-09T16:43:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/survival-in-patients-with-malignant-pleural-effusion-undergoing-talc-pleurodesis/ 2019-09-16T14:07:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/determination-of-mesothelin-levels-in-pleural-effusion-does-not-help-predict-survival-of-patients-with-malignant-pleural-mesothelioma/ 2019-09-16T14:45:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/localized-malignant-mesothelioma-an-unusual-and-poorly-characterized-neoplasm-of-serosal-origin-best-current-evidence-from-the-literature-and-the-international-mesothelioma-panel/ 2019-09-16T15:03:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/proceedings-of-the-american-society-of-cytopathology-companion-session-at-the-2019-united-states-and-canadian-academy-of-pathology-annual-meeting-part-2-effusion-cytology-with-focus-on-theranostics/ 2019-09-16T16:22:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/epha2-mutations-with-oncogenic-characteristics-in-squamous-cell-lung-cancer-and-malignant-pleural-mesothelioma/ 2019-09-16T15:36:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-has-anything-changed/ 2019-09-23T14:44:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/monoclonal-caveolin-1-expression-in-the-differential-diagnosis-of-malignant-pleural-mesothelioma-and-pulmonary-adenocarcinoma-is-it-useful/ 2019-09-23T14:58:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-immunohistochemistry-studies-in-distinguishing-malignant-mesothelioma-from-metastatic-lung-carcinoma-in-malignant-pleural-effusion/ 2019-09-23T15:12:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-fgfr1-4-in-malignant-pleural-mesothelioma-tissue-and-corresponding-cell-lines-and-its-relationship-to-patient-survival-and-fgfr-inhibitor-sensitivity/ 2019-09-23T15:32:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/pfkfb3-inhibition-reprograms-malignant-pleural-mesothelioma-to-nutrient-stress-induced-macropinocytosis-and-er-stress-as-independent-binary-adaptive-responses/ 2019-09-30T14:47:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/volumetric-modulated-arc-therapy-after-lung-sparing-surgery-for-malignant-pleural-mesothelioma-a-single-institution-experience/ 2019-10-01T13:44:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-analysis-of-a-patient-with-neurofibromatosis-2-nf2-and-peritoneal-malignant-mesothelioma/ 2019-10-07T13:39:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-in-construction-workers-the-apulia-regional-mesothelioma-register-southern-italy/ 2019-10-07T13:54:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/bortezomib-sensitivity-is-tissue-dependent-and-high-expression-of-the-20s-proteasome-precludes-good-response-in-malignant-pleural-mesothelioma/ 2019-10-10T13:47:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/fluorescence-in-situ-hybridization-fish-provides-estimates-of-minute-and-interstitial-bap1-cdkn2a-and-nf2-gene-deletions-in-peritoneal-mesothelioma/ 2019-10-10T14:19:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/fluorescence-in-situ-hybridization-fish-provides-estimates-of-minute-and-interstitial-bap1-cdkn2a-and-nf2-gene-deletions-in-peritoneal-mesothelioma-2/ 2019-10-14T14:00:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/can-novel-adipokines-asprosin-and-meteorin-like-be-biomarkers-for-malignant-mesothelioma/ 2019-10-14T14:21:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-and-characterization-of-a-new-malignant-peritoneal-mesothelioma-cell-line-kog-1-from-the-ascitic-fluid-of-a-patient-with-pemetrexed-chemotherapy-resistance/ 2019-10-14T15:35:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/types-of-surgery-post-neoadjuvant-chemotherapy-for-pleural-mesothelioma/ 2019-10-14T16:02:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/approved-and-emerging-treatments-of-malignant-pleural-mesothelioma-in-elderly-patients/ 2019-10-14T16:25:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/endoplasmic-reticulum-stress-signaling-as-a-therapeutic-target-in-malignant-pleural-mesothelioma/ 2019-10-21T13:57:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/localized-biphasic-malignant-peritoneal-mesothelioma-presenting-as-a-rectal-tumor/ 2019-10-21T16:39:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/sirtuin-family-members-selectively-regulate-autophagy-in-osteosarcoma-and-mesothelioma-cells-in-response-to-cellular-stress/ 2019-10-21T17:48:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumour-treating-fields-in-combination-with-pemetrexed-and-cisplatin-or-carboplatin-as-first-line-treatment-for-unresectable-malignant-pleural-mesothelioma-stellar-a-multicentre-single-arm-phase-2/ 2019-10-28T14:53:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/patient-experiences-of-participation-in-a-radical-thoracic-surgical-trial-findings-from-the-mesothelioma-and-radical-surgery-trial-2-mars-2/ 2019-10-28T14:56:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/posterior-intercostal-lymph-nodes-double-recurrence-and-death-risk-in-malignant-pleural-mesothelioma/ 2019-10-28T15:06:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/why-be-one-protein-when-you-can-affect-many-the-multiple-roles-of-yb-1-in-lung-cancer-and-mesothelioma/ 2019-10-28T15:26:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/cd70-expression-correlates-with-a-worse-prognosis-in-malignant-pleural-mesothelioma-patients-via-immune-evasion-and-enhanced-invasiveness/ 2019-10-28T15:40:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-value-of-computed-tomography-imaging-features-in-malignant-pleural-mesothelioma/ 2019-11-04T15:01:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/primary-malignant-mesothelioma-of-the-peritoneum-mistaken-for-peritoneal-tuberculosis-due-to-elevated-cancer-antigen-125/ 2019-11-04T16:06:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/redefining-malignant-pleural-mesothelioma-types-as-a-continuum-uncovers-immune-vascular-interactions/ 2019-11-04T16:47:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/detection-of-anaplastic-lymphoma-kinase-rearranged-mesothelioma-cells-in-ascites-by-companion-diagnostics/ 2019-11-04T17:14:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-mortality-in-great-britain-how-much-longer-will-dockyards-dominate/ 2019-11-04T17:39:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/extrapleural-pneumonectomies-for-pleural-mesothelioma/ 2019-11-11T14:39:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/modulation-of-calretinin-expression-in-human-mesothelioma-cells-reveals-the-implication-of-the-fak-and-wnt-signaling-pathways-in-conferring-chemoresistance-towards-cisplatin/ 2019-11-11T15:55:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-occurrence-of-asbestos-related-diseases-among-former-employees-of-asbestos-processing-plants-in-poland/ 2019-11-11T16:48:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-construction-and-analysis-of-cerna-network-and-patterns-of-immune-infiltration-in-mesothelioma-with-bone-metastasis/ 2019-11-11T16:59:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/globular-c1q-receptor-gc1qr-p32-habp1-is-overexpressed-in-malignant-pleural-mesothelioma-and-is-associated-with-increased-survival-in-surgical-patients-treated-with-chemotherapy/ 2019-11-11T17:25:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/crispr-screening-identifies-wee1-as-a-combination-target-for-standard-chemotherapy-in-malignant-pleural-mesothelioma/ 2019-11-18T15:14:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-mtor-signaling-pathway-is-associated-with-the-prognosis-of-malignant-pleural-mesothelioma-after-multimodality-therapy/ 2019-11-18T15:41:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/follow-up-of-the-libby-montana-screening-cohort-a-17-year-mortality-study/ 2019-11-18T16:15:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-value-of-bap1-expression-and-cdkn2a-deletion-to-distinguish-peritoneal-malignant-mesothelioma-from-peritoneal-location-of-carcinoma-in-effusion-cytology-specimens/ 2019-11-18T16:56:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-among-employees-of-a-connecticut-factory-that-manufactured-friction-materials-using-chrysotile-asbestos-an-update/ 2019-11-18T17:31:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/intraperitoneal-delivery-of-chemotherapeutic-agents-for-the-treatment-of-peritoneal-metastases-current-challenges-and-how-to-overcome-them/ 2019-11-25T14:38:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/screening-of-occupational-exposure-to-asbestos-and-silica-by-job-exposure-matrix-among-patients-with-lung-cancer-and-mesothelioma/ 2019-11-26T15:00:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-yap1-signaling-inhibitors-verteporfin-and-ca3-suppress-the-mesothelioma-cancer-stem-cell-phenotype/ 2019-11-27T14:37:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/elevated-circulating-activin-a-levels-in-patients-with-malignant-pleural-mesothelioma-are-related-to-cancer-cachexia-and-reduced-response-to-platinum-based-chemotherapy/ 2019-11-27T17:19:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/secretome-of-pleural-effusions-associated-with-non-small-cell-lung-cancer-nsclc-and-malignant-mesothelioma-therapeutic-implications/ 2019-11-27T17:24:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-and-lung-cancer-the-role-of-asbestos-exposure-and-genetic-variants-in-selected-iron-metabolism-and-inflammation-genes/ 2019-12-02T17:12:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-cyclin-dependent-kinase-7-down-regulates-yes-associated-protein-expression-in-mesothelioma-cells/ 2019-12-02T18:25:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-signatures-for-combined-targeted-treatments-in-diffuse-malignant-peritoneal-mesothelioma/ 2019-12-02T18:41:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-prospective-observational-study-of-on-treatment-plasma-homocysteine-levels-as-a-biomarker-of-toxicity-depression-and-vitamin-supplementation-lead-in-time-pre-pemetrexed-in-patients-with-non-small/ 2019-12-02T21:42:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-calcium-signalling-in-malignant-mesothelioma/ 2019-12-02T21:59:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/anaplastic-lymphoma-kinase-alk-gene-rearrangement-in-children-and-young-adults-with-mesothelioma/ 2019-12-09T14:58:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/detection-of-tgf-%ce%b2-in-pleural-effusions-for-diagnosis-and-prognostic-stratification-of-malignant-pleural-mesothelioma/ 2019-12-09T16:23:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-cells-depend-on-the-anti-apoptotic-protein-bcl-xl-for-survival-and-are-sensitized-to-ionizing-radiation-by-bh3-mimetics/ 2019-12-09T17:29:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-results-of-laparoscopic-cytoreductive-surgery-and-hipec-for-the-curative-treatment-of-low-grade-pseudomyxoma-peritonei-and-multicystic-mesothelioma/ 2019-12-09T17:56:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-benefit-from-immune-modulation-and-anti-inflammatory-treatment-in-metastatic-mesothelioma/ 2019-12-09T18:36:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/brief-report-novel-germline-mutations-in-dna-damage-repair-in-patients-with-malignant-pleural-mesotheliomas/ 2020-01-07T15:36:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-ii-study-of-pazopanib-in-patients-with-malignant-pleural-mesothelioma-ncctg-n0623-alliance/ 2020-01-08T14:53:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-diffuse-mesothelioma-in-women-a-study-of-354-cases/ 2020-01-09T15:01:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-germline-mutation-with-iridociliochoroidal-melanoma-and-malignant-peritoneal-mesothelioma/ 2020-01-13T15:13:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-gene-expression-based-test-can-outperform-bap1-and-p16-analyses-in-the-differential-diagnosis-of-pleural-mesothelial-proliferations/ 2020-01-13T15:37:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-epithelioid-malignant-mesothelioma-of-the-pleura-presenting-as-a-hydropneumothorax-and-vertebral-body-invasion/ 2020-01-13T16:55:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/implantation-and-monitoring-by-pet-ct-of-an-orthotopic-model-of-human-pleural-mesothelioma-in-athymic-mice/ 2020-01-13T17:57:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-ii-trial-of-single-oral-fgf-inhibitor-azd4547-as-second-or-third-line-therapy-in-malignant-pleural-mesothelioma/ 2020-01-13T18:22:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/combined-mek-and-pi3k-p110b-inhibition-as-a-novel-targeted-therapy-for-malignant-mesothelioma-displaying-sarcomatoid-features/ 2020-01-20T16:42:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/lox-family-and-zfpm2-as-novel-diagnostic-biomarkers-for-malignant-pleural-mesothelioma/ 2020-01-20T17:14:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/dosimetric-comparison-of-lung-sparing-radiation-therapy-between-volumetric-arc-therapy-and-helical-tomotherapy-for-unresectable-malignant-pleural-mesothelioma/ 2020-01-20T17:35:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/screening-of-pleural-mesothelioma-cell-lines-for-kinase-activity-may-identify-new-mechanisms-of-therapy-resistance-in-patients-receiving-platin-based-chemotherapy/ 2020-01-20T18:23:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/well-differentiated-papillary-mesothelioma-with-omental-calcifications-a-case-report-and-review-of-the-literature/ 2020-01-20T18:56:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/frequent-homozygous-deletions-of-type-i-interferon-genes-in-pleural-mesothelioma-confer-sensitivity-to-oncolytic-measles-virus/ 2020-01-27T16:00:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-outcomes-with-recurrence-after-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2020-01-27T16:43:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/predictions-of-mortality-from-pleural-mesothelioma-in-italy-after-the-ban-of-asbestos-use/ 2020-01-27T17:13:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/repression-of-oncogenic-cap-mediated-translation-by-4ei-10-diminishes-proliferation-enhances-chemosensitivity-and-alters-expression-of-malignancy-related-proteins-in-mesothelioma/ 2020-01-27T17:48:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/what-is-the-optimal-preoperative-imaging-modality-for-assessing-peritoneal-cancer-index-an-analysis-from-the-united-states-hipec-collaborative/ 2020-01-27T18:28:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-feature-of-diagnostic-challenging-cases-for-pleural-biopsy-in-patient-with-malignant-pleural-mesothelioma/ 2020-02-03T15:59:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/indications-for-hyperthermic-intraperitoneal-chemotherapy-with-cytoreductive-surgery-a-systematic-review/ 2020-02-03T16:46:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/microenvironment-dependent-gradient-of-ctl-exhaustion-in-the-ae17sova-murine-mesothelioma-tumor-model/ 2020-02-03T17:28:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/sensitivity-of-mesothelioma-cells-to-parp-inhibitors-is-not-dependent-on-bap1-but-is-enhanced-by-temozolomide-in-cells-with-high-schlafen-11and-low-mgmt-expression/ 2020-02-03T17:44:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/18f-fluorodeoxyglucose-positron-emission-tomography-in-malignant-pleural-mesothelioma-diagnostic-and-prognostic-performance-and-its-correlation-to-pathological-results/ 2020-02-03T18:45:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-and-surgical-outcomes-of-patients-with-peritoneal-mesothelioma-discussed-at-a-monthly-national-multidisciplinary-team-video-conference-meeting/ 2020-02-10T16:03:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/predictors-and-outcomes-of-surgery-in-peritoneal-mesothelioma-an-analysis-of-2000-patients-from-the-national-cancer-database/ 2020-02-11T16:26:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/deep-learning-based-segmentation-of-malignant-pleural-mesothelioma-tumor-on-computed-tomography-scans-application-to-scans-demonstrating-pleural-effusion/ 2020-02-13T14:46:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-neoadjuvant-chemotherapy-in-patients-with-resectable-malignant-pleural-mesothelioma-an-institutional-and-national-analysis/ 2020-02-13T15:50:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-levels-of-pd-l1-in-mesothelioma-patients-from-the-nibit-meso-1-study-correlation-with-survival/ 2020-02-17T15:42:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/differential-diagnosis-of-malignant-pleural-mesothelioma-on-cytology-a-gene-expression-panel-versus-bap1-and-p16-tests/ 2020-02-17T17:59:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-intraparenchymal-mesothelioma-an-atypical-presentation/ 2020-02-17T18:20:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/effusion-cytology-of-malignant-mesothelioma-enables-earlier-diagnosis-and-recognizes-patients-with-better-prognosis/ 2020-02-17T19:13:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/light-fluence-rate-and-tissue-oxygenation-st-o2-distributions-within-the-thoracic-cavity-of-patients-receiving-intraoperative-photodynamic-therapy-for-malignant-pleural-mesothelioma/ 2020-02-17T21:33:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/infrared-navigation-system-for-light-dosimetry-during-pleural-photodynamic-therapy/ 2020-02-24T14:50:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/exhaled-breath-analysis-in-diagnosis-of-malignant-pleural-mesothelioma-systematic-review/ 2020-02-24T15:51:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/lung-asbestos-fibre-burden-and-pleural-mesothelioma-in-women-with-non-occupational-exposure/ 2020-02-24T15:50:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/survival-of-malignant-mesothelioma-and-other-rare-thoracic-cancers-in-germany-and-the-united-states-a-population-based-study/ 2020-02-24T17:09:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-in-vivo-immunohistochemical-study-on-macroh2a-1-in-lung-and-lymph-node-tissues-exposed-to-an-asbestiform-fiber/ 2020-02-24T17:40:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/impressive-clinical-response-to-anti-pd-1-therapy-in-epithelioid-mesothelioma-with-high-clonal-pd-l1-expression-and-eml4-alk-rearrangement/ 2020-03-02T15:33:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/disease-related-outcomes-and-toxicities-of-intensity-modulated-radiation-therapy-following-lung-sparing-pleurectomy-for-malignant-pleural-mesothelioma-a-systematic-review/ 2020-03-02T15:32:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/lurbinectedin-as-second-or-third-line-palliative-therapy-in-malignant-pleural-mesothelioma-an-international-multi-centre-single-arm-phase-ii-trial-sakk-17-16/ 2020-03-02T15:43:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/genetic-alterations-of-malignant-pleural-mesothelioma-association-to-tumor-heterogeneity-and-overall-survival/ 2020-03-02T16:04:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-imaging-in-malignant-pleural-mesothelioma-an-update-after-the-2018-bts-guidelines/ 2020-03-02T16:41:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-evidence-and-future-perspectives-of-immune-checkpoint-inhibitors-in-unresectable-malignant-pleural-mesothelioma/ 2020-03-11T13:37:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-ii-study-of-the-combination-of-gemcitabine-and-imatinib-mesylate-in-pemetrexed-pretreated-patients-with-malignant-pleural-mesothelioma/ 2020-03-11T13:47:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/routine-surveillance-for-diagnosis-of-venous-thromboembolism-after-pleurectomy-for-malignant-pleural-mesothelioma/ 2020-03-11T13:59:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-cells-secrete-natriuretic-peptides-data-and-diagnostic-clinical-implications/ 2020-03-16T14:06:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/photodynamic-therapy-based-dendritic-cell-vaccination-suited-to-treat-peritoneal-mesothelioma/ 2020-03-16T14:14:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/histopathological-features-of-epithelioid-malignant-pleural-mesotheliomas-in-patients-with-extended-survival/ 2020-03-16T14:34:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-mesothelial-inclusion-cyst-presenting-in-a-40-year-old-woman-as-abdominal-pain-and-bloating-a-rare-diagnosis/ 2020-03-16T14:42:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/adar2-regulates-malignant-behaviour-of-mesothelioma-cells-independent-of-rna-editing-activity/ 2020-03-16T14:54:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/how-i-treat-malignant-pleural-mesothelioma/ 2020-03-23T13:38:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-in-malignant-pleural-mesothelioma/ 2020-03-23T13:52:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/curcumin-as-an-anticancer-agent-in-malignant-mesothelioma-a-review/ 2020-03-23T13:51:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-molecular-and-pathological-evaluation-of-transitional-mesothelioma-assisted-by-deep-learning-approach-a-multi-institutional-study-of-the-international-mesothelioma-panel-from-mesopath-r/ 2020-03-23T14:40:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparative-analysis-of-prognostic-histopathologic-parameters-in-subtypes-of-epithelioid-pleural-mesothelioma/ 2020-03-23T15:19:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-following-repeated-exposures-to-cosmetic-talc-a-case-series-of-75-patients/ 2020-03-30T13:52:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/igg4-related-pleural-disease-with-aortitis-and-submandibular-glands-involvement-successfully-treated-with-corticosteroid-case-based-review/ 2020-04-06T14:54:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgery-for-pleural-mesothelioma-when-it-is-indicated-and-why-arguments-against-surgery-for-malignant-pleural-mesothelioma/ 2020-04-06T15:31:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/measurement-of-asbestos-emissions-associated-with-demolition-of-abandoned-residential-dwellings/ 2020-04-06T16:10:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/randomised-placebo-controlled-cross-over-study-examining-the-role-of-anamorelin-in-mesothelioma-the-anthem-study-rationale-and-protocol/ 2020-04-06T16:37:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/predictors-of-outcome-of-pleurodesis-in-patients-with-malignant-pleural-effusion-a-systematic-review-and-meta-analysis/ 2020-04-06T16:57:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/emerging-treatments-for-malignant-pleural-mesothelioma-where-are-we-heading/ 2020-04-14T14:27:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumour-cell-pd-l1-expression-is-prognostic-in-patients-with-malignant-pleural-effusion-the-impact-of-c-reactive-protein-and-immune-checkpoint-inhibition/ 2020-04-15T16:54:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/overexpression-of-mir-199-214-is-a-distinctive-feature-of-iron-and-asbestos-induced-sarcomatoid-mesothelioma-in-rats/ 2020-04-16T14:36:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-trials-eligibility-of-patients-with-malignant-pleural-mesothelioma-use-of-novel-therapies-and-outcomes/ 2020-04-16T15:18:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/association-between-asbestos-exposure-and-pericardial-and-tunica-vaginalis-testis-malignant-mesothelioma-a-case-control-study-and-epidemiological-remarks/ 2020-04-20T14:14:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/permanent-diabetes-insipidus-in-a-patient-with-mesothelioma-treated-with-immunotherapy/ 2020-04-22T15:06:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgery-for-mesothelioma-after-radiation-therapy-smart-a-single-institution-experience/ 2020-04-22T16:44:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/detection-of-circulating-tumor-cells-ctcs-in-malignant-pleural-mesothelioma-mpm-with-the-universal-ctc-chip-and-an-anti-podoplanin-antibody-nz-1-2/ 2020-04-22T17:17:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-air-pollution-description-of-a-mesothelioma-cluster-due-to-residential-exposure-from-an-asbestos-cement-factory/ 2020-04-27T14:44:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/prmt5-silencing-selectively-affects-mtap-deleted-mesothelioma-in-vitro-evidence-of-a-novel-promising-approach/ 2020-04-28T14:24:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/dextrose-containing-carrier-solution-for-hyperthermic-intraperitoneal-chemotherapy-increased-intraoperative-hyperglycemia-and-postoperative-complications/ 2020-04-29T14:47:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/micrornas-diagnostic-and-prognostic-value-as-predictive-markers-for-malignant-mesothelioma/ 2020-04-30T13:56:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/defense-and-protection-mechanisms-in-lung-exposed-to-asbestiform-fiber-the-role-of-macrophage-migration-inhibitory-factor-and-heme-oxygenase-1/ 2020-05-01T14:27:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-epigenetic-biomarkers-in-malignant-pleural-mesothelioma-state-of-the-art-and-critical-evaluation/ 2020-05-04T14:00:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/extracellular-vesicles-as-biomarkers-in-malignant-pleural-mesothelioma-a-review/ 2020-05-05T14:32:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/modulation-of-microrna-expression-levels-after-naturally-occurring-asbestiform-fibers-exposure-as-a-diagnostic-biomarker-of-mesothelial-neoplastic-transformation/ 2020-05-05T14:52:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/chromatographic-detection-of-8-hydroxy-2-deoxyguanosine-in-leukocytes-of-asbestos-exposed-workers-for-assessing-past-and-recent-carcinogen-exposures/ 2020-05-05T15:05:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeted-phototherapy-for-malignant-pleural-mesothelioma-near-infrared-photoimmunotherapy-targeting-podoplanin/ 2020-05-05T15:37:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-and-clinicopathological-utility-of-programmed-death-ligand-1-in-malignant-pleural-mesothelioma-a-meta-analysis/ 2020-05-11T14:50:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-analysis-in-short-and-long-term-patients-with-malignant-pleura-mesothelioma-treated-with-palliative-chemotherapy/ 2020-05-11T15:32:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/putative-biomarkers-for-malignant-pleural-mesothelioma-suggested-by-proteomic-analysis-of-cell-secretome/ 2020-05-11T16:06:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-report-of-malignant-primary-pericardial-mesothelioma-with-atypical-imaging-appearance-multimodality-imaging-with-histopathological-correlation/ 2020-05-11T16:41:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/differences-in-cancer-survival-by-remoteness-of-residence-an-analysis-of-data-from-a-population-based-cancer-registry/ 2020-05-11T17:42:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-patterns-among-patients-with-malignant-pleural-mesothelioma-an-italian-population-based-nationwide-study/ 2020-05-18T16:11:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-response-monitoring-in-patients-with-advanced-malignancies-using-cell-free-shox2-and-sept9-dna-methylation-in-blood-an-observational-prospective-study/ 2020-05-18T17:36:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-epidemiological-surveillance-of-malignant-mesothelioma-in-italy-1993-2015-methods-findings-and-research-perspectives/ 2020-05-19T14:22:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/localized-biphasic-malignant-mesothelioma-presenting-as-a-giant-pelvic-wall-mass-a-rare-case-report-and-literature-review/ 2020-05-19T15:48:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/survivin-expression-as-an-independent-predictor-of-overall-survival-in-malignant-peritoneal-mesothelioma/ 2020-05-19T16:33:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-genetic-and-microenviromental-heterogeneity-as-an-unexpected-reading-frame-and-therapeutic-challenge/ 2020-05-27T15:42:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/use-of-programmed-death-ligand-1-pd-l1-staining-to-separate-sarcomatoid-malignant-mesotheliomas-from-benign-mesothelial-reactions/ 2020-05-27T16:26:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/gender-differences-in-molecular-guided-therapy-recommendations-for-metastatic-malignant-mesothelioma/ 2020-05-27T18:21:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/heg1-bap1-and-mtap-are-useful-in-cytologic-diagnosis-of-malignant-mesothelioma-with-effusion/ 2020-06-01T15:12:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/acidosis-induced-tgf-%ce%b22-production-promotes-lipid-droplet-formation-in-dendritic-cells-and-alters-their-potential-to-support-anti-mesothelioma-t-cell-response/ 2020-06-01T15:40:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/metformin-loaded-chitosomes-for-treatment-of-malignant-pleural-mesothelioma-a-rare-thoracic-cancer/ 2020-06-01T17:23:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/ers-ests-eacts-estro-guidelines-for-the-management-of-malignant-pleural-mesothelioma/ 2020-06-01T18:09:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-hippo-pathway-as-a-driver-of-select-human-cancers/ 2020-06-01T18:10:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/initial-evaluation-of-nivolumab-in-patients-with-post-operative-recurrence-of-malignant-pleural-mesothelioma/ 2020-06-08T14:25:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/amrubicin-in-previously-treated-patients-with-malignant-pleural-mesothelioma-a-phase-ii-study/ 2020-06-08T16:52:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/breast-metastasis-as-the-initial-presentation-of-malignant-pleural-mesothelioma/ 2020-06-15T20:56:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/cisplatin-plus-pemetrexed-therapy-and-subsequent-immune-checkpoint-inhibitor-administration-for-malignant-peritoneal-mesothelioma-without-pleural-lesions-case-report/ 2020-06-17T15:45:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/impairments-in-bowel-function-social-function-and-quality-of-life-after-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy/ 2020-06-17T16:57:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/role-of-inflammation-in-the-malignant-transformation-of-pleural-mesothelial-cells-induced-by-multi-walled-carbon-nanotubes/ 2020-06-25T17:15:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/addition-of-radiotherapy-to-surgery-and-chemotherapy-improves-survival-in-localized-malignant-pleural-mesothelioma-a-surveillance-epidemiology-and-end-results-seer-study/ 2020-06-25T20:29:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-based-ancillary-assays-offer-improved-diagnostic-yield-of-effusion-cytology-with-potential-challenges-in-malignant-pleural-mesothelioma/ 2020-06-29T15:23:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnosis-of-a-primary-pericardial-mesothelioma-by-the-combination-of-conventional-echocardiography-and-contrast-echocardiography/ 2020-06-29T15:48:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/ntrk-and-alk-rearrangements-in-malignant-pleural-mesothelioma-pulmonary-neuroendocrine-tumours-and-non-small-cell-lung-cancer/ 2020-06-29T17:27:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/secondary-renal-amyloidosis-associated-with-asbestos-related-pleuropulmonary-diseases/ 2020-06-29T17:37:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/nlrp3-and-card8-polymorphisms-influence-risk-for-asbestos-related-diseases/ 2020-06-29T17:52:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-profiling-of-multiple-primary-cancers-including-synchronous-lung-adenocarcinoma-and-bilateral-malignant-mesotheliomas-identification-of-a-novel-bap1-germline-variant/ 2020-07-06T14:21:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/cellular-immunotherapy-and-locoregional-administration-of-car-t-cells-in-malignant-pleural-mesothelioma/ 2020-07-06T14:31:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/involvement-of-the-m-csf-il-34-csf-1r-pathway-in-malignant-pleural-mesothelioma/ 2020-07-06T14:48:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/predicting-cancer-using-supervised-machine-learning-mesothelioma/ 2020-07-06T17:29:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/questioning-the-prognostic-role-of-bap-1-immunohistochemistry-in-malignant-pleural-mesothelioma-a-single-center-experience-with-systematic-review-and-meta-analysis/ 2020-07-06T18:17:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/verification-of-a-blood-based-targeted-proteomics-signature-for-malignant-pleural-mesothelioma/ 2020-08-10T18:27:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/mitochondrial-ros-induce-partial-dedifferentiation-of-human-mesothelioma-via-upregulation-of-nanog/ 2020-08-11T14:26:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/mapping-the-interactome-of-the-nuclear-heparan-sulfate-proteoglycan-syndecan-1-in-mesothelioma-cells/ 2020-08-12T15:27:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-src-family-kinases-in-mesothelioma-time-to-upgrade/ 2020-08-13T15:25:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/nucleolin-and-nucleophosmin-expression-patterns-in-pulmonary-adenocarcinoma-invading-the-pleura-and-in-pleural-malignant-mesothelioma/ 2020-08-13T15:47:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/ganetespib-in-combination-with-pemetrexed-platinum-chemotherapy-in-patients-with-pleural-mesothelioma-meso-02-a-phase-ib-trial/ 2020-08-17T15:30:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/progress-in-the-understanding-of-the-immune-microenvironment-and-immunotherapy-in-malignant-pleural-mesothelioma/ 2020-08-17T17:01:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/testing-for-bap1-loss-and-cdkn2a-p16-homozygous-deletion-improves-the-accurate-diagnosis-of-mesothelial-proliferations-in-effusion-cytology/ 2020-08-18T15:04:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/possible-reversibility-between-epithelioid-and-sarcomatoid-types-of-mesothelioma-is-independent-of-erc-mesothelin-expression/ 2020-08-18T15:37:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/delayed-phase-enhancement-for-evaluation-of-malignant-pleural-mesothelioma-on-computed-tomography-a-prospective-cohort-study/ 2020-08-18T16:26:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/laser-ablation-inductively-coupled-plasma-mass-spectrometry-as-a-novel-clinical-imaging-tool-to-detect-asbestos-fibres-in-malignant-mesothelioma/ 2020-08-24T16:33:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-biomarkers-a-review-highlighting-contributions-from-the-early-detection-research-network/ 2020-08-24T16:57:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/primary-malignant-pericardial-mesothelioma-presenting-with-cardiac-tamponade/ 2020-08-24T17:20:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/dual-inhibition-of-cdk4-6-and-pi3k-akt-mtor-signaling-impairs-energy-metabolism-in-mpm-cancer-cells/ 2020-08-24T17:56:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/nivolumab-induced-immune-thrombocytopenia-in-a-patient-with-malignant-pleural-mesothelioma/ 2020-08-24T18:04:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-vistas-in-malignant-mesothelioma-microrna-architecture-and-nrf2-mapk-signal-transduction/ 2020-08-31T14:54:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/dual-inhibition-of-cdk4-6-and-pi3k-akt-mtor-signaling-impairs-energy-metabolism-in-mpm-cancer-cells-2/ 2020-09-01T17:25:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/headspace-analysis-of-mesothelioma-cell-lines-differentiates-biphasic-and-epithelioid-sub-types/ 2020-09-01T20:45:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/randomized-study-of-maintenance-pemetrexed-versus-observation-for-treatment-of-malignant-pleural-mesothelioma-calgb-30901/ 2020-09-01T20:53:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/determinants-of-plasma-calretinin-in-patients-with-malignant-pleural-mesothelioma/ 2020-09-01T20:59:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/verification-of-a-blood-based-targeted-proteomics-signature-for-malignant-pleural-mesothelioma-2/ 2020-09-08T17:42:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/trabectedin-in-malignant-pleural-mesothelioma-results-from-the-multicentre-single-arm-phase-ii-atreus-study/ 2020-09-09T15:25:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/using-creative-co-design-to-develop-a-decision-support-tool-for-people-with-malignant-pleural-effusion/ 2020-09-09T15:47:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/advances-with-pharmacotherapy-for-peritoneal-metastasis/ 2020-09-09T18:09:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/symptom-burden-and-unmet-needs-in-mpm-exploratory-analyses-from-the-respect-meso-study/ 2020-09-14T17:06:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/initial-clinical-experience-treating-patients-with-palliative-radiotherapy-for-malignant-pleural-mesothelioma-on-the-halcyontm-linear-accelerator/ 2020-09-14T20:39:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/evolution-of-genomic-and-t-cell-repertoire-heterogeneity-of-malignant-pleural-mesothelioma-under-dasatinib-treatment/ 2020-09-14T20:52:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/systematic-analysis-of-aberrant-biochemical-networks-and-potential-drug-vulnerabilities-induced-by-tumor-suppressor-loss-in-malignant-pleural-mesothelioma/ 2020-09-14T21:06:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-a-five-gene-signature-for-predicting-survival-in-malignant-pleural-mesothelioma-patients/ 2020-09-14T21:16:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-a-five-gene-signature-for-predicting-survival-in-malignant-pleural-mesothelioma-patients-2/ 2020-09-21T17:10:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-nonresponse-bias-in-a-case-control-study-of-pleural-mesothelioma/ 2020-09-21T17:36:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/multicystic-peritoneal-mesothelioma-treated-with-complete-cytoreductive-surgery-peritonectomy-and-hyperthermic-intra-peritoneal-chemotherapy-a-case-report/ 2020-09-21T17:47:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-conceives-feii-dependent-mutagenic-stromal-milieu-through-ceaseless-macrophage-ferroptosis-and-%ce%b2-catenin-induction-in-mesothelium/ 2020-09-21T18:06:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-1-study-of-the-immunotoxin-lmb-100-in-patients-with-mesothelioma-and-other-solid-tumors-expressing-mesothelin/ 2020-09-21T18:30:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-imidazo21-b134thiadiazole-derivatives-inhibit-fak-phosphorylation-and-potentiate-the-antiproliferative-effects-of-gemcitabine-through-modulation-of-the-human-equilibrative-nucleoside-trans/ 2020-10-05T16:11:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-potential-utility-of-gata-binding-protein-3-for-diagnosis-of-malignant-pleural-mesotheliomas/ 2020-10-05T16:42:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/durvalumab-with-first-line-chemotherapy-in-previously-untreated-malignant-pleural-mesothelioma-dream-a-multicentre-single-arm-phase-2-trial-with-a-safety-run-in/ 2020-10-05T17:33:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/tissue-expression-of-lactate-transporters-mct1-and-mct4-and-prognosis-of-malignant-pleural-mesothelioma-brief-report/ 2020-10-05T17:54:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/association-of-tumour-mutational-burden-with-outcomes-in-patients-with-advanced-solid-tumours-treated-with-pembrolizumab-prospective-biomarker-analysis-of-the-multicohort-open-label-phase-2-keynote/ 2020-10-05T18:33:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/foxp3-regulatory-t-cell-depletion-after-nonablative-oligofractionated-irradiation-boosts-the-abscopal-effects-in-murine-malignant-mesothelioma/ 2020-10-14T17:10:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-multicentre-randomised-phase-iii-trial-comparing-pembrolizumab-vs-single-agent-chemotherapy-for-advanced-pre-treated-malignant-pleural-mesothelioma-the-european-thoracic-oncology-platform-etop-9-1/ 2020-10-14T17:39:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/axl-inactivation-inhibits-mesothelioma-growth-and-migration-via-regulation-of-p53-expression/ 2020-10-14T18:11:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/selection-of-micrornas-in-extracellular-vesicles-for-diagnosis-of-malignant-pleural-mesothelioma-by-in-vitro-analysis/ 2020-10-26T15:01:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-induces-mesothelial-cell-transformation-via-hmgb1-driven-autophagy/ 2020-10-26T16:16:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-for-mesothelioma-rationale-and-new-approaches/ 2020-10-26T16:57:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-phosphatase-ptpn1-ptp1b-is-a-candidate-marker-of-better-chemotherapy-response-in-metastatic-high-grade-serous-carcinoma/ 2020-10-26T17:50:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-and-efficacy-of-novel-mab806-antibody-drug-conjugates-in-malignant-mesothelioma/ 2020-10-26T18:51:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-potential-hub-genes-and-therapeutic-drugs-in-malignant-pleural-mesothelioma-by-integrated-bioinformatics-analysis/ 2020-11-02T16:38:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/locoregional-control-and-toxicity-after-pleurectomy-decortication-and-intensity-modulated-pleural-radiation-therapy-in-patients-with-malignant-pleural-mesothelioma/ 2020-11-02T17:06:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/effect-of-asbestos-exposure-on-differentiation-and-function-of-cytotoxic-t-lymphocytes/ 2020-11-02T17:18:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-liquid-biopsy-for-detecting-circulating-mesothelial-precursor-cells-a-new-biomarker-for-diagnosis-and-prognosis-in-mesothelioma/ 2020-11-02T18:38:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/crs-hipec-with-major-organ-resection-in-peritoneal-mesothelioma-does-not-impact-major-complications-or-overall-survival-a-retrospective-cohort-study-of-the-us-hipec-collaborative/ 2020-11-03T16:01:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-influence-of-genetic-variability-in-il1b-and-mir146a-on-the-risk-of-pleural-plaques-and-malignant-mesothelioma/ 2020-11-09T17:09:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-risk-among-those-exposed-to-chrysotile-asbestos-only-and-mixtures-that-include-amphibole-a-case-control-study-in-the-usa-1975-1980/ 2020-11-09T17:27:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/complications-and-predictive-factors-for-air-leak-10-days-with-neoadjuvant-chemotherapy-followed-by-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2020-11-10T16:55:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/heterogeneity-in-pd-l1-expression-in-malignant-peritoneal-mesothelioma-with-systemic-or-intraperitoneal-chemotherapy/ 2020-11-09T18:53:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-metallothionein-knockdown-on-cisplatin-resistance-in-malignant-pleural-mesothelioma/ 2020-11-10T18:18:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/widespread-pulmonary-invasion-by-malignant-pleural-mesothelioma-an-important-diagnostic-consideration/ 2020-11-16T16:11:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/calcitriol-inhibits-viability-and-proliferation-in-human-malignant-pleural-mesothelioma-cells/ 2020-11-16T17:27:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-value-of-ct-guided-percutaneous-fine-needle-aspiration-biopsy-for-peritoneal-lesions/ 2020-11-16T18:39:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/can-bap1-expression-loss-in-mesothelial-cells-be-an-indicator-of-malignancy/ 2020-11-16T19:04:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/oncolytic-herpesvirus-therapy-for-mesothelioma-a-phase-i-iia-trial-of-intrapleural-administration-of-hsv1716/ 2020-11-18T16:01:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-nivolumab-and-ipilimumab-in-patients-with-malignant-pleural-mesothelioma-is-related-to-a-subtype-of-effector-memory-cytotoxic-t-cells-translational-evidence-from-two-clinical-trials/ 2020-11-30T16:51:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/advanced-symptom-management-system-for-patients-with-malignant-pleural-mesothelioma-asymsmeso-mixed-methods-study/ 2020-11-30T18:15:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/homozygous-deletion-of-cdkn2a-in-malignant-mesothelioma-diagnostic-utility-patient-characteristics-and-survival-in-a-uk-mesothelioma-centre/ 2020-12-01T16:01:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/exploration-of-identifying-novel-serum-biomarkers-for-malignant-mesothelioma-using-itraq-combined-with-2d-lc-ms-ms/ 2020-12-01T16:32:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/somatic-epigenetic-silencing-of-ripk3-inactivates-necroptosis-and-contributes-to-chemoresistance-in-malignant-mesothelioma/ 2020-12-01T18:22:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/characterization-of-soluble-pd-l1-in-pleural-effusions-of-mesothelioma-patients-potential-implications-in-the-immune-response-and-prognosis/ 2020-12-07T16:36:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/dna-methylation-of-fkbp5-as-predictor-of-overall-survival-in-malignant-pleural-mesothelioma/ 2020-12-07T22:24:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarker-guided-targeted-and-immunotherapies-in-malignant-pleural-mesothelioma/ 2020-12-08T16:33:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-bcl-2-family-proteins-and-therapeutic-potential-of-bh3-mimetics-in-malignant-pleural-mesothelioma/ 2020-12-08T22:40:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyperthermic-intraoperative-intrapleural-chemotherapy-and-surgical-cytoreduction-as-part-of-multimodal-treatment-of-malignant-pleural-mesothelioma-case-report-m-szkorupa1-d-klos1-j-chudacek1-j/ 2020-12-08T22:31:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/prolonged-survival-after-multimodal-therapy-for-pleural-mesothelioma-dont-give-up-the-follow-up-a-case-report/ 2020-12-14T16:06:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/distant-cutaneous-metastasis-of-malignant-epithelioid-mesothelioma/ 2020-12-14T16:34:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-laparoscopy-improves-staging-of-malignant-pleural-mesothelioma-with-routine-pet-imaging/ 2020-12-14T17:49:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-laparoscopy-improves-staging-of-malignant-pleural-mesothelioma-with-routine-pet-imaging-2/ 2020-12-16T18:23:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/programmed-cell-death-1-ligand-1-pd-l1-expression-is-associated-with-poor-prognosis-of-malignant-pleural-mesothelioma-patients-with-good-performance-status/ 2020-12-16T19:02:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleurectomy-decortication-in-the-treatment-of-malignant-pleural-mesothelioma-encouraging-results-and-novel-prognostic-implications-based-on-experience-in-355-consecutive-patients/ 2021-01-04T16:40:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/drug-repositioning-screening-identified-fludarabine-and-risedronic-acid-as-potential-therapeutic-compounds-for-malignant-pleural-mesothelioma/ 2021-01-05T15:38:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-impact-on-outcome-by-adding-bevacizumab-to-standard-induction-chemotherapy-prior-to-mesothelioma-surgery-a-retrospective-single-center-analysis/ 2021-01-05T17:41:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-intensity-statins-are-associated-with-improved-clinical-activity-of-pd-1-inhibitors-in-malignant-pleural-mesothelioma-and-advanced-non-small-cell-lung-cancer-patients/ 2021-01-05T21:52:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/follow-up-of-soluble-mesothelin-related-protein-levels-in-participants-with-asbestos-related-disorders/ 2021-01-05T22:30:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/sensitive-blood-based-detection-of-asbestos-associated-diseases-using-cysteine-rich-angiogenic-inducer-61-as-circulating-protein-biomarker/ 2021-01-11T16:16:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-neoplasm-with-both-differentiation-of-epithelioid-mesothelioma-and-squamous-cell-carcinoma-a-rare-phenomena/ 2021-01-12T15:14:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-features-and-surgical-outcomes-of-major-urological-interventions-during-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotheraphy/ 2021-01-12T15:43:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibitors-of-the-transcription-factor-stat3-decrease-growth-and-induce-immune-response-genes-in-models-of-malignant-pleural-mesothelioma-mpm/ 2021-01-12T16:16:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/correlation-of-mtap-protein-expression-with-mtap-and-cdkn2a-copy-number-in-malignant-pleural-mesothelioma/ 2021-01-12T16:34:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/cost-effectiveness-of-malignant-pleural-effusion-with-indwelling-catheter-systematic-review/ 2021-01-18T15:07:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-novel-potent-tead-inhibitor-k-975-inhibits-yap1-taz-tead-protein-protein-interactions-and-exerts-an-anti-tumor-effect-on-malignant-pleural-mesothelioma/ 2021-01-18T15:40:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/correlation-of-mtap-protein-expression-with-mtap-and-cdkn2a-copy-number-in-malignant-pleural-mesothelioma-2/ 2021-01-18T16:15:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-and-characterization-of-patient-derived-xenografts-pdxs-of-different-histology-from-malignant-pleural-mesothelioma-patients/ 2021-01-18T16:52:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/living-with-mesothelioma-a-qualitative-study-of-the-experiences-of-male-military-veterans-in-the-uk/ 2021-01-18T18:37:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgery-for-malignant-pleural-mesothelioma-after-radiotherapy-smart-final-results-from-a-single-centre-phase-2-trial/ 2021-01-25T15:24:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-egfr-and-conformational-forms-of-egfr-in-malignant-pleural-mesothelioma-and-its-impact-on-survival/ 2021-01-25T15:43:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-search-for-an-interesting-partner-to-combine-with-pd-l1-blockade-in-mesothelioma-focus-on-tim-3-and-lag-3/ 2021-01-25T16:00:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-and-histopathological-study-of-patient-derived-xenograft-models-and-primary-cell-lines-of-epithelioid-malignant-peritoneal-mesothelioma/ 2021-01-25T18:39:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/first-line-nivolumab-plus-ipilimumab-in-unresectable-malignant-pleural-mesothelioma-checkmate-743-a-multicentre-randomised-open-label-phase-3-trial/ 2021-01-26T15:02:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/fluorescence-in-situ-hybridization-detection-of-chromosome-22-monosomy-in-pleural-effusion-cytology-for-the-diagnosis-of-mesothelioma/ 2021-02-01T18:41:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/higher-concordance-of-pd-l1-expression-between-biopsies-and-effusions-in-epithelioid-than-in-nonepithelioid-pleural-mesothelioma/ 2021-02-01T18:54:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/recurrence-of-mesothelioma-after-a-macroscopic-complete-resection-procedure-is-a-second-radical-surgery-justified/ 2021-02-01T20:35:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-prognostic-factors-in-pleural-mesothelioma-best-supportive-care-and-anti-tumor-treatments-in-a-real-life-setting/ 2021-02-01T21:31:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/unusual-radiologic-presentations-of-malignant-peritoneal-mesothelioma/ 2021-02-02T16:40:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/rucaparib-in-patients-with-bap1-deficient-or-brca1-deficient-mesothelioma-mist1-an-open-label-single-arm-phase-2a-clinical-trial/ 2021-02-08T16:36:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/switch-maintenance-gemcitabine-after-first-line-chemotherapy-in-patients-with-malignant-mesothelioma-nvalt19-an-investigator-initiated-randomised-open-label-phase-2-trial/ 2021-02-08T18:59:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/strn-alk-rearranged-pediatric-malignant-peritoneal-mesothelioma-functional-testing-of-527-cancer-drugs-in-patient-derived-cancer-cells/ 2021-02-08T22:04:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-in-a-patient-with-pneumothorax-a-cumbersome-subtype-both-clinically-and-pathologically/ 2021-02-09T16:30:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/metformin-induces-apoptosis-and-inhibits-notch1-in-malignant-pleural-mesothelioma-cells/ 2021-02-09T17:46:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-ct-convolution-kernel-on-robustness-of-radiomic-features-for-different-lung-diseases-and-tissue-types/ 2021-02-15T16:22:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-polymorphisms-in-glutathione-related-genes-in-asbestos-related-diseases/ 2021-02-15T16:36:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/alterations-in-bap1-are-associated-with-cisplatin-resistance-through-inhibition-of-apoptosis-in-malignant-pleural-mesothelioma-mpm/ 2021-02-15T18:50:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-malignant-peritoneal-mesothelioma-with-strn-exon-2-and-alk-exon-20-a-case-report-and-literature-review/ 2021-02-15T19:13:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/potential-role-of-serum-mesothelin-in-predicting-survival-of-patients-with-malignant-pleural-mesothelioma/ 2021-02-15T19:21:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-soluble-mesothelin-related-protein-smrp-and-fibulin-3-levels-correlate-with-baseline-malignant-pleural-mesothelioma-mpm-tumor-volumes-but-are-not-useful-as-biomarkers-of-response-in-an-immun/ 2021-02-22T16:56:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/enhanced-anti-tumor-efficacy-of-il-7-ccl19-producing-human-car-t-cells-in-orthotopic-and-patient-derived-xenograft-tumor-models/ 2021-02-23T16:52:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/syndecan-1-overexpressing-mesothelioma-cells-inhibit-proliferation-wound-healing-and-tube-formation-of-endothelial-cells/ 2021-02-23T17:24:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/gata3-is-a-useful-immunohistochemical-marker-for-distinguishing-sarcomatoid-malignant-mesothelioma-from-lung-sarcomatoid-carcinoma-and-organizing-pleuritis/ 2021-02-23T18:09:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/outcomes-of-conversion-to-extrapleural-pneumonectomy-from-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2021-02-23T21:57:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/outcomes-of-conversion-to-extrapleural-pneumonectomy-from-pleurectomy-decortication-for-malignant-pleural-mesothelioma-2/ 2021-03-01T18:36:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/eliminating-mesothelioma-by-aav-vectored-pd1-based-vaccination-in-the-tumor-microenvironment/ 2021-03-02T16:27:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/patients-and-family-caregivers-report-high-treatment-expectations-during-palliative-chemotherapy-a-longitudinal-prospective-study/ 2021-03-02T18:01:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-without-asbestos-exposure-diagnosed-during-egfr-tki-treatment-of-lung-adenocarcinoma-a-case-report/ 2021-03-02T18:23:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/intussusception-caused-by-small-intestine-metastasis-of-malignant-pleural-mesothelioma-a-case-report/ 2021-03-08T16:37:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-factors-for-progression-free-and-overall-survival-in-malignant-pleural-mesothelioma/ 2021-03-08T18:09:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-1-cohort-expansion-study-of-ly3023414-a-dual-pi3k-mtor-inhibitor-in-patients-with-advanced-mesothelioma/ 2021-03-08T18:42:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/investigating-the-impact-of-target-lesion-selection-on-drug-effect-evaluation-and-tumour-growth-rate-determination-using-tumour-growth-inhibition-models-example-of-malignant-pleural-mesothelioma-pati/ 2021-03-09T17:21:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/traf7-mutations-and-immunohistochemical-study-of-uterine-adenomatoid-tumor-compared-to-malignant-mesothelioma/ 2021-03-09T18:36:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/investigating-the-impact-of-target-lesion-selection-on-drug-effect-evaluation-and-tumour-growth-rate-determination-using-tumour-growth-inhibition-models-example-of-malignant-pleural-mesothelioma-pat-2/ 2021-03-15T16:26:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/traf7-mutations-and-immunohistochemical-study-of-uterine-adenomatoid-tumor-compared-to-malignant-mesothelioma-2/ 2021-03-16T15:24:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/prophylactic-irradiation-of-tracts-in-patients-with-malignant-pleural-mesothelioma-a-systematic-review-and-meta-analysis-of-randomized-trials/ 2021-03-16T20:57:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/outcomes-of-multicystic-peritoneal-mesothelioma-treatment-with-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy/ 2021-03-16T21:14:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/use-of-preclinical-models-for-malignant-pleural-mesothelioma/ 2021-03-16T21:48:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-expression-patterns-and-prognostic-significance-of-pleckstrin-homology-like-domain-family-a-phlda-in-lung-cancer-and-malignant-mesothelioma/ 2021-03-22T19:53:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/accuracy-of-pleural-biopsy-for-the-diagnosis-of-histologic-subtype-of-malignant-pleural-mesothelioma-necropsy-based-study-of-134-cases/ 2021-03-22T21:01:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/metastasis-of-sarcomatoid-malignant-mesothelioma-with-p16-cdkn2a-deletion-manifested-as-a-subcutaneous-mass-in-the-back-a-case-report-and-review-of-literature/ 2021-03-23T20:45:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/clonal-architecture-in-mesothelioma-is-prognostic-and-shapes-the-tumour-microenvironment/ 2021-03-23T21:18:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-second-line-treatment-and-prognostic-factors-in-patients-with-advanced-malignant-peritoneal-mesothelioma-a-retrospective-study/ 2021-03-23T21:39:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-patterns-and-outcomes-of-patients-with-advanced-malignant-pleural-mesothelioma-in-a-community-practice-setting/ 2021-03-29T14:54:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-prognostic-value-of-18f-fluorodeoxyglucose-positron-emission-tomography-computed-tomography-parameters-in-patients-with-malignant-pleural-mesothelioma/ 2021-03-29T15:05:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/interobserver-variability-of-quantitative-and-qualitative-assessment-using-mri-in-malignant-pleural-mesothelioma/ 2021-03-30T14:54:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-sensitivity-of-pd-l1-analysis-from-pleural-effusion-in-nonsmall-cell-lung-cancer/ 2021-03-30T15:21:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/utility-of-sox6-and-dab2-for-the-diagnosis-of-malignant-mesothelioma/ 2021-04-05T15:12:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/bisecting-glcnac-on-asn388-is-characteristic-to-erc-mesothelin-expressed-on-epithelioid-mesothelioma-cells/ 2021-04-05T16:02:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/transcriptional-perturbation-of-protein-arginine-methyltransferase-5-exhibits-mtap-selective-oncosuppression/ 2021-04-05T16:50:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/response-to-immune-checkpoint-inhibitor-therapy-in-patients-with-unresectable-recurrent-malignant-pleural-mesothelioma-shown-by-fdg-pet-and-ct/ 2021-04-12T16:51:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/nf2-and-canonical-hippo-yap-pathway-define-distinct-tumor-subsets-characterized-by-different-immune-deficiency-and-treatment-implications-in-human-pleural-mesothelioma/ 2021-04-12T17:35:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/premature-phase-ii-study-of-amrubicin-as-palliative-chemotherapy-for-previously-treated-malignant-pleural-mesothelioma/ 2021-04-12T20:32:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/p14-arf-positive-malignant-pleural-mesothelioma-a-phenotype-with-distinct-immune-microenvironment/ 2021-04-13T16:53:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-clinical-experience-and-prognostic-value-of-derived-neutrophil-to-lymphocyte-ratio-and-pd-l1-expression/ 2021-04-13T18:26:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/incidence-of-mesothelioma-and-asbestosis-by-occupation-in-a-diverse-workforce/ 2021-04-19T17:15:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-clinical-experience-and-prognostic-value-of-derived-neutrophil-to-lymphocyte-ratio-and-pd-l1-expression-2/ 2021-04-19T17:52:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/l1cam-expression-in-cystic-mesothelial-lesions-a-comparison-with-adenomatoid-tumors-well-differentiated-papillary-mesothelial-tumors-and-malignant-mesotheliomas/ 2021-04-20T17:04:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/tertiary-lymphoid-structures-in-epithelioid-malignant-peritoneal-mesothelioma-are-associated-with-neoadjuvant-chemotherapy-but-not-with-prognosis/ 2021-04-20T20:33:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-co-opts-bcl-x-l-and-autophagy-to-escape-apoptosis/ 2021-04-20T20:39:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/sulforaphane-inhibits-prmt5-and-mep50-function-to-suppress-the-mesothelioma-cancer-cell-phenotype/ 2021-04-26T16:20:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/effect-of-il-15-addition-on-asbestos-induced-suppression-of-human-cytotoxic-t-lymphocyte-induction/ 2021-04-26T17:51:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/transcriptomic-alterations-in-malignant-pleural-mesothelioma-cells-in-response-to-long%e2%80%91term-treatment-with-bullfrog-sialic-acid%e2%80%91binding-lectin/ 2021-04-26T20:27:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/bric-59-study-first-results-and-considerations-on-the-pathway-on-the-access-to-health-care-for-malignant-pleural-mesotheliomas/ 2021-04-27T20:42:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-nontoxic-dose-of-chrysotile-can-malignantly-transform-met-5a-cells-in-which-microrna-28-has-inhibitory-effects/ 2021-05-03T16:17:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/three-decades-of-malignant-pleural-mesothelioma-an-academic-center-experience/ 2021-05-03T21:20:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/unusually-favorable-outcome-of-6-consecutive-patients-with-diffuse-malignant-peritoneal-mesothelioma-treated-with-repeated-doses-of-intraperitoneal-paclitaxel-a-case-series/ 2021-05-04T19:53:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/complete-laparoscopic-pelvic-peritonectomy-plus-hyperthermic-intraperitoneal-chemotherapy/ 2021-05-04T20:30:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-the-histone-methyltransferase-ezh2-enhances-protumor-monocyte-recruitment-in-human-mesothelioma-spheroids/ 2021-05-04T20:47:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelin-expression-in-human-tumors-a-tissue-microarray-study-on-12679-tumors/ 2021-05-10T16:50:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/sarcomatoid-mesothelioma-a-clinicopathological-and-immunohistochemical-study-of-64-cases/ 2021-05-10T17:21:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-current-therapy-of-asbestos-associated-malignant-pleural-mesothelioma-an-expert-consensus-paper/ 2021-05-11T19:02:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/gender-and-the-experiences-of-living-with-mesothelioma-a-thematic-analysis/ 2021-05-11T19:23:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/emerging-biological-therapies-for-the-treatment-of-malignant-pleural-mesothelioma/ 2021-05-11T19:33:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-surgery-plus-hipec-with-and-without-nipec-for-malignant-peritoneal-mesothelioma-a-propensity-matched-analysis/ 2021-05-17T15:57:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/does-the-lent-score-risk-stratify-patients-with-malignant-pleural-mesothelioma-an-observational-study/ 2021-05-17T20:18:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/cxcr4-engagement-triggers-cd47-internalization-and-antitumor-immunization-in-a-mouse-model-of-mesothelioma/ 2021-05-18T20:00:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/overexpression-of-microrna%e2%80%91486-affects-the-proliferation-and-chemosensitivity-of-mesothelioma-cell-lines-by-targeting-pim1/ 2021-05-18T20:22:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-tumor-cell-platelet-derived-growth-factor-receptor-beta-expression-is-associated-with-shorter-survival-in-malignant-pleural-epithelioid-mesothelioma/ 2021-05-18T20:33:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/medical-thoracoscopy-computed-tomography-guided-biopsy-and-ultrasound-guided-biopsy-for-malignant-pleural-mesothelioma-a-systematic-review/ 2021-05-24T16:48:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/emerging-avenues-in-immunotherapy-for-the-management-of-malignant-pleural-mesothelioma/ 2021-05-24T17:32:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-safety-and-cost-minimization-analysis-of-continuous-infusion-of-low-dose-gemcitabine-plus-cisplatin-in-patients-with-unresectable-malignant-pleural-mesothelioma/ 2021-05-25T17:11:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/quality-of-life-and-lung-function-after-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2021-05-25T17:35:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-comparison-of-surgery-based-trimodality-therapy-to-medical-therapy-at-two-tertiary-academic-institutions/ 2021-05-25T21:21:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/histopathological-typing-in-diffuse-malignant-epithelioid-mesothelioma-implication-for-prognosis-and-molecular-basis/ 2021-06-01T17:13:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/extrapleural-pneumonectomy-versus-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2021-06-01T17:31:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/combined-analysis-of-rna-sequence-and-microarray-data-reveals-a-competing-endogenous-rna-network-as-novel-prognostic-markers-in-malignant-pleural-mesothelioma/ 2021-06-01T20:03:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/car-t-cell-therapy-for-pleural-mesothelioma-rationale-preclinical-development-and-clinical-trials/ 2021-06-02T17:28:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-nuclear-grade-necrosis-and-histologic-subtype-between-biopsy-and-resection-in-pleural-malignant-mesothelioma/ 2021-06-02T17:47:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-nuclear-grade-necrosis-and-histologic-subtype-between-biopsy-and-resection-in-pleural-malignant-mesothelioma-2/ 2021-06-07T16:11:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/metastasis-associated-gene-1-mta1-enhances-cisplatin-resistance-of-malignant-pleural-mesothelioma-by-atr-chk1-mediated-dna-repair/ 2021-06-07T20:54:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-usefulness-of-biomarkers-in-diagnosis-of-asbestos-induced-malignant-pleural-mesothelioma/ 2021-06-08T23:11:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-fluid-has-pro-growth-biological-properties-which-enable-cancer-cell-proliferation/ 2021-06-08T23:23:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/microrna-206-suppresses-mesothelioma-progression-via-the-ras-signaling-axis/ 2021-06-08T23:29:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-association-between-pleural-fluid-exposure-and-survival-in-pleural-mesothelioma/ 2021-06-14T16:15:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-usefulness-of-biomarkers-in-diagnosis-of-asbestos-induced-malignant-pleural-mesothelioma-2/ 2021-06-14T20:38:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/microrna-206-suppresses-mesothelioma-progression-via-the-ras-signaling-axis-2/ 2021-06-15T20:01:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/assessment-of-interferon-%ce%b3-in-pleural-fluid-as-a-prognostic-factor-of-survival-in-malignant-pleural-mesothelioma/ 2021-06-15T20:11:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-lrrk2-mutations-and-other-rare-non-bap1-related-candidate-tumor-predisposition-gene-variants-in-high-risk-cancer-families-with-mesothelioma-and-other-tumors/ 2021-06-15T20:26:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/controversies-in-the-role-of-radiotherapy-in-pleural-mesothelioma/ 2021-06-21T19:38:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/epidemiology-diagnosis-and-treatment-of-the-malignant-pleural-mesothelioma-a-narrative-review-of-literature/ 2021-06-22T17:34:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/non-incisional-pleurectomy-decortication-for-malignant-pleural-mesothelioma-2/ 2021-06-22T20:59:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-circulating-tumor-cell-detection-chip-combining-conventional-podoplanin-and-egfr-antibodies-for-all-histological-malignant-pleural-mesothelioma/ 2021-06-22T21:07:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-utility-of-bap1-for-malignant-pleural-mesothelioma-in-pleural-fluid-specimens-with-atypical-morphology/ 2021-06-22T21:36:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-prognostic-and-bone-metastasis%e2%80%8b-related-alternative-splicing-signatures-in-mesothelioma/ 2021-06-28T19:27:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-value-of-cytology-in-distinguishing-malignant-mesothelioma-an-institutional-experience-of-210-cases-reclassified-according-to-the-international-system-for-reporting-serous-fluid-cytopathology-is/ 2021-06-28T20:00:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-bh3-mimetic-azd0466-targeting-bcl-xl-and-bcl-2-is-effective-in-pre-clinical-models-of-malignant-pleural-mesothelioma/ 2021-06-29T20:01:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-of-unenhanced-ct-based-imaging-signature-for-bap1-mutation-status-prediction-in-malignant-pleural-mesothelioma-consideration-of-2d-and-3d-segmentation/ 2021-06-29T20:27:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/old-borders-and-new-horizons-in-multimodality-imaging-of-malignant-pleural-mesothelioma/ 2021-06-29T20:39:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/update-on-diagnosing-and-reporting-malignant-pleural-mesothelioma/ 2021-07-06T20:20:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/nipu-a-randomised-open-label-phase-ii-study-evaluating-nivolumab-and-ipilimumab-combined-with-uv1-vaccination-as-second-line-treatment-in-patients-with-malignant-mesothelioma/ 2021-07-06T18:15:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/pathological-characterization-of-tumor-immune-microenvironment-time-in-malignant-pleural-mesothelioma/ 2021-07-06T20:37:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgical-management-and-reconstruction-of-diaphragm-pericardium-and-chest-wall-in-mesothelioma-surgery-a-review/ 2021-07-06T20:45:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-dna-methylation-signals-for-malignant-pleural-mesothelioma-risk-assessment/ 2021-07-06T20:59:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/essential-role-of-the-histone-lysine-demethylase-kdm4a-in-the-biology-of-malignant-pleural-mesothelioma-mpm/ 2021-07-12T19:53:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-impact-of-adjuvant-hemithoracic-radiation-on-outcomes-in-patients-with-stage-i-iii-malignant-pleural-mesothelioma-a-dual-registry-analysis/ 2021-07-12T20:05:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/feasibility-and-outcomes-of-cytoreductive-surgery-and-hipec-for-peritoneal-surface-malignancies-in-low-and-middle-income-countries-a-single-center-experience-of-232-cases/ 2021-07-12T20:28:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/immune-checkpoint-inhibition-for-unresectable-malignant-pleural-mesothelioma/ 2021-07-13T19:49:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/oxytocin-receptor-is-a-promising-therapeutic-target-of-malignant-mesothelioma/ 2021-07-13T20:02:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/deep-learning-based-classification-distinguishes-sarcomatoid-malignant-mesotheliomas-from-benign-spindle-cell-mesothelial-proliferations/ 2021-07-19T18:10:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-association-between-pleural-fluid-exposure-and-survival-in-pleural-mesothelioma-2/ 2021-07-19T18:18:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/cldn15-is-a-novel-diagnostic-marker-for-malignant-pleural-mesothelioma/ 2021-07-19T21:19:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/deep-learning-with-deep-convolutional-neural-network-using-fdg-pet-ct-for-malignant-pleural-mesothelioma-diagnosis/ 2021-07-19T21:26:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-hipec-with-cisplatin-in-pediatric-patients-with-peritoneal-mesothelioma-a-single-institution-experience-and-long-term-follow-up/ 2021-07-19T21:34:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/detection-of-circulating-immunosuppressive-cytokines-in-malignant-pleural-mesothelioma-patients-for-prognostic-stratification/ 2021-07-26T14:21:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/combined-grade-and-nuclear-grade-are-prognosis-predictors-of-epithelioid-malignant-peritoneal-mesothelioma-a-multi-institutional-retrospective-study/ 2021-07-26T16:19:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/cellular-cannibalism-and-consequent-thrombocytopenia-in-a-patient-with-bone-marrow-metastasis-of-malignant-pleural-mesothelioma-a-case-report/ 2021-07-27T19:36:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/monocytic-ontogeny-of-regenerated-macrophages-characterizes-the-mesotheliomagenic-responses-to-carbon-nanotubes/ 2021-07-27T19:54:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-ebc-plasma-mirna-signature-discriminates-lung-adenocarcinomas-from-pleural-mesothelioma-and-healthy-controls/ 2021-08-30T17:39:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/lurbinectedin-in-refractory-diffuse-malignant-peritoneal-mesothelioma-report-of-two-cases/ 2021-08-02T15:59:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/inherited-predisposition-to-malignant-mesothelioma-germline-bap1-mutations-and-beyond/ 2021-08-30T17:39:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/patterns-of-peritoneal-dissemination-and-response-to-systemic-chemotherapy-in-common-and-rare-peritoneal-tumours-treated-by-cytoreductive-surgery-study-protocol-of-a-prospective-multicentre-observa/ 2021-08-30T17:39:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-mdm2-inhibitor-achieves-synergistic-cytotoxic-effects-with-adenoviruses-lacking-e1b55kda-gene-on-mesothelioma-with-the-wild-type-p53-through-augmenting-nfi-expression/ 2021-08-30T17:39:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/membranous-heg1-expression-is-a-useful-marker-in-the-differential-diagnosis-of-epithelioid-and-biphasic-malignant-mesothelioma-versus-carcinomas/ 2021-08-30T17:39:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/when-cardiac-surgery-comes-to-its-limits-a-case-report-of-pericardial-mesothelioma-invading-the-myocardium/ 2021-08-09T15:06:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/ubqln4-is-an-atm-substrate-that-stabilizes-the-anti-apoptotic-proteins-bcl2a1-and-bcl2l10-in-mesothelioma/ 2021-08-30T17:38:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/squamous-differentiation-in-surgically-resected-malignant-pleural-mesothelioma-with-neoadjuvant-chemotherapy/ 2021-08-30T17:38:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/recent-patent-based-perspective-on-diagnostic-and-therapeutic-interventions-in-malignant-mesothelioma-is-drug-repositioning-knocking-the-door/ 2021-08-16T17:52:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-utility-of-bap1-ezh2-and-survivin-in-differentiating-pleural-epithelioid-mesothelioma-and-reactive-mesothelial-hyperplasia-immunohistochemical-study/ 2021-08-16T17:52:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-pathogenesis-of-mesothelioma-is-driven-by-a-dysregulated-translatome/ 2021-08-16T17:43:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-updating-of-biological-functions-of-methyltransferase-setdb1-and-its-relevance-in-lung-cancer-and-mesothelioma/ 2021-08-17T16:40:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/blocking-the-gitr-gitrl-pathway-to-overcome-resistance-to-therapy-in-sarcomatoid-malignant-pleural-mesothelioma/ 2021-08-30T17:37:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparative-effectiveness-of-second-line-immune-checkpoint-inhibitor-therapy-versus-chemotherapy-for-malignant-pleural-mesothelioma/ 2021-08-30T17:37:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/cerebral-air-embolism-after-indwelling-pleural-catheter-insertion-in-a-chronic-hydropneumothorax-secondary-to-epithelioid-mesothelioma/ 2021-08-30T17:38:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-showing-rare-morphology-indistinguishable-from-myxofibrosarcoma-concomitant-with-egfr-mutated-lung-adenocarcinoma-a-case-report/ 2021-08-23T14:22:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-use-of-a-next-generation-sequencing-derived-machine-learning-risk-prediction-model-oncocast-mpm-for-malignant-pleural-mesothelioma-a-retrospective-study/ 2021-08-30T17:36:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/perioperative-anaesthetic-management-of-patients-undergoing-thoracic-cytoreductive-surgery-and-hithoc/ 2021-08-30T17:36:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/combination-of-plasma-based-metabolomics-and-machine-learning-algorithm-provides-a-novel-diagnostic-strategy-for-malignant-mesothelioma/ 2021-08-30T17:35:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-with-heterologous-elements/ 2021-08-30T17:35:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-with-heterologous-elements-2/ 2021-08-30T16:06:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-thoracic-surgery-combined-with-hyperthermic-chemoperfusion-for-pleural-malignancies-a-single-center-experience/ 2021-08-31T13:30:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-pathogenesis-of-mesothelioma-is-driven-by-a-dysregulated-translatome-2/ 2021-09-07T15:25:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-novel-cox-2-cyp19a1-axis-involved-in-the-mesothelioma-pathogenesis-opens-new-therapeutic-opportunities/ 2021-09-07T15:25:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/sox6-expression-is-sensitive-for-peritoneal-epithelioid-malignant-mesothelioma-but-not-specific-in-the-differential-diagnosis-with-tubo-ovarian-serous-neoplasia/ 2021-09-07T15:25:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/neoadjuvant-pemetrexed-plus-cisplatin-followed-by-pleurectomy-for-malignant-pleural-mesothelioma/ 2021-09-07T15:25:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/mitogen-signal-associated-pathways-energy-metabolism-regulation-and-mediation-of-tumor-immunogenicity-play-essential-roles-in-the-cellular-response-of-malignant-pleural-mesotheliomas-to-platinum-bas/ 2021-09-20T15:07:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/dosimetric-comparison-between-helical-tomotherapy-and-volumetric-modulated-arc-therapy-in-patients-with-malignant-pleural-mesothelioma/ 2021-09-20T15:07:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/examining-the-impact-of-physical-function-performance-in-predicting-patient-outcomes-after-lung-sparing-surgery-for-malignant-pleural-mesothelioma/ 2021-09-20T15:07:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/loss-of-methylthioadenosine-phosphorylase-by-immunohistochemistry-is-common-in-pulmonary-sarcomatoid-carcinoma-and-sarcomatoid-mesothelioma/ 2021-09-13T15:29:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/state-of-the-art-cytology-of-pleural-fluid-focusing-on-the-diagnosis-of-mesothelioma/ 2021-09-20T15:07:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/evidence-based-diagnostic-performance-of-novel-biomarkers-for-the-diagnosis-of-malignant-mesothelioma-in-effusion-cytology/ 2021-09-20T15:06:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-treating-fields-ttfields-downregulate-the-fanconi-anemia-brca-pathway-and-increase-the-efficacy-of-chemotherapy-in-malignant-pleural-mesothelioma-preclinical-models/ 2021-09-20T15:06:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/profile-of-soluble-factors-in-pleural-effusions-predict-prognosis-in-mesothelioma/ 2021-09-20T15:06:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/management-of-advanced-pleural-mesothelioma-at-the-crossroads/ 2021-09-20T15:06:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/gemcitabine-with-or-without-ramucirumab-as-second-line-treatment-for-malignant-pleural-mesothelioma-rames-a-randomised-double-blind-placebo-controlled-phase-2-trial/ 2021-09-20T17:22:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/significance-of-p53-immunostaining-in-mesothelial-proliferations-and-correlation-with-tp53-mutation-status/ 2021-09-20T18:17:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyperthermic-intrathoracic-chemotherapy-for-malignant-pleural-mesothelioma-the-forefront-of-surgery-based-multimodality-treatment/ 2021-09-20T20:03:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/goecp-seor-clinical-guidelines-on-radiotherapy-for-malignant-pleural-mesothelioma/ 2021-09-20T20:26:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-correlation-between-ct-imaging-features-and-histologic-subtypes/ 2021-09-27T14:50:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/goecp-seor-clinical-guidelines-on-radiotherapy-for-malignant-pleural-mesothelioma-2/ 2021-09-27T15:05:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/four-immune-related-genes-fn1-ugcg-chpf2-and-thbs2-as-potential-diagnostic-and-prognostic-biomarkers-for-carbon-nanotube-induced-mesothelioma/ 2021-09-27T15:21:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/environmental-asbestos-exposure-and-clustering-of-malignant-mesothelioma-in-community-a-spatial-analysis-in-a-population-based-case-control-study/ 2021-09-27T16:02:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/investigating-the-efficacy-of-zingerone-on-mesothelioma-and-the-role-of-trpv1-in-this-effect/ 2021-09-27T16:43:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/investigating-the-efficacy-of-zingerone-on-mesothelioma-and-the-role-of-trpv1-in-this-effect-2/ 2021-10-04T15:00:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-characterization-of-pleomorphic-mesothelioma-a-multi-institutional-study/ 2021-10-04T15:13:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/surface-fill-hydrogel-attenuates-the-oncogenic-signature-of-complex-anatomical-surface-cancer-in-a-single-application/ 2021-10-04T15:39:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/integrated-genomics-point-to-immune-vulnerabilities-in-pleural-mesothelioma/ 2021-10-04T16:27:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyperthermic-intrathoracic-chemotherapy-hitoc-after-cytoreductive-surgery-for-pleural-malignancies-a-retrospective-multicentre-study/ 2021-10-04T17:34:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/integrated-genomics-point-to-immune-vulnerabilities-in-pleural-mesothelioma-2/ 2021-10-11T16:16:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyperthermic-intrathoracic-chemotherapy-hitoc-after-cytoreductive-surgery-for-pleural-malignancies-a-retrospective-multicentre-study-2/ 2021-10-11T16:41:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/matrix-metalloproteinases-as-biomarkers-and-treatment-targets-in-mesothelioma-a-systematic-review/ 2021-10-11T16:48:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-cdk4-6-overcomes-primary-resistance-to-pd-1-blockade-in-malignant-mesothelioma/ 2021-10-11T16:59:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/immune-checkpoint-inhibitor-uptake-in-real-world-patients-with-malignant-pleural-mesothelioma/ 2021-10-11T17:08:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-and-yy1-regulate-expression-of-death-receptors-in-malignant-pleural-mesothelioma/ 2021-10-25T18:05:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-therapeutic-strategy-targeting-the-mesenchymal-phenotype-of-malignant-pleural-mesothelioma-by-suppressing-lsd1/ 2021-10-25T19:39:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/reic-dkk-3-gene-therapy-induces-immunogenic-cell-death-in-a-mouse-model-of-malignant-mesothelioma/ 2021-10-25T19:54:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/postoperative-empyema-after-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2021-10-25T20:16:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/quinacrine-has-preferential-anticancer-effects-on-mesothelioma-cells-with-inactivating-nf2-mutations/ 2021-10-25T20:43:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-rare-case-of-benign-multicystic-peritoneal-mesothelioma-misdiagnosed-as-hydatid-cyst-found-in-the-liver-parenchyma-and-abdomen-cavity-of-a-male-with-asbestos-exposure/ 2021-11-08T16:54:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/computed-tomography-and-spirometry-can-predict-unresectability-in-malignant-pleural-mesothelioma/ 2021-11-08T19:49:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/upregulation-of-thymidylate-synthase-induces-pemetrexed-resistance-in-malignant-pleural-mesothelioma/ 2021-11-08T19:56:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/thoracic-mesenchymal-malignant-tumors-and-programed-cell-death-ligand-1-status-clinicopathologic-and-prognostic-analysis-of-eight-pulmonary-sarcomatoid-carcinomas-and-eight-malignant-mesotheliomas/ 2021-11-08T21:06:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-2-study-of-olaparib-in-malignant-mesothelioma-and-correlation-of-efficacy-with-germline-or-somatic-mutations-in-bap1-gene/ 2021-11-08T21:30:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-3-adenosine-and-p2x7-purinergic-receptors-as-new-targets-for-an-innovative-pharmacological-therapy-of-malignant-pleural-mesothelioma/ 2021-11-15T18:03:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/short-57-kb-cdkn2a-fish-probe-effectively-detects-short-homozygous-deletion-of-the-9p21-locus-in-malignant-pleural-mesothelioma/ 2021-11-15T18:12:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/actl6a-suppresses-p21-cip1-tumor-suppressor-expression-to-maintain-an-aggressive-mesothelioma-cancer-cell-phenotype/ 2021-11-15T18:19:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/preclinical-evaluation-of-podoplanin-targeted-alpha-radioimmunotherapy-with-the-novel-antibody-nz-16-for-malignant-mesothelioma/ 2021-11-15T20:15:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/extracellular-vesicle-enriched-mir-625-3p-is-associated-with-survival-of-malignant-mesothelioma-patients/ 2021-11-15T20:25:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-patterns-and-outcomes-in-older-patients-with-advanced-malignant-pleural-mesothelioma-analyses-of-surveillance-epidemiology-and-end-results-medicare-data/ 2021-11-29T17:33:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/prediction-modeling-using-routine-clinical-parameters-to-stratify-survival-in-malignant-pleural-mesothelioma-patients-complicated-with-malignant-pleural-effusion/ 2021-11-29T17:52:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/non-resectable-malignant-peritoneal-mesothelioma-treated-with-pressurized-intraperitoneal-aerosol-chemotherapy-pipac-plus-systemic-chemotherapy-could-lead-to-secondary-complete-cytoreductive-surgery/ 2021-11-29T18:19:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/jme-001-phase-ii-trial-of-first-line-combination-chemotherapy-with-cisplatin-pemetrexed-and-nivolumab-for-unresectable-malignant-pleural-mesothelioma/ 2021-11-29T18:52:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-rarest-of-the-rare-a-case-of-bap1-mutated-primary-peritoneal-mesothelioma/ 2021-11-29T21:33:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/anticancer-agent-%ce%b1-sulfoquinovosyl-acylpropanediol-enhances-the-radiosensitivity-of-human-malignant-mesothelioma-in-nude-mouse-models/ 2021-12-06T15:41:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/highly-sensitive-quantification-of-pemetrexed-in-human-plasma-using-uplc-ms-ms-to-support-microdosing-studies/ 2021-12-06T16:40:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/histology-of-the-pleural-rind-at-18-ffdg-pet-ct-hot-and-cold-spots-in-mesothelioma-patients-after-talc-pleurodesis-and-neoadjuvant-chemotherapy/ 2021-12-06T17:50:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/durvalumab-with-platinum-pemetrexed-for-unresectable-pleural-mesothelioma-survival-genomic-and-immunologic-analyses-from-the-phase-2-pre0505-trial/ 2021-12-06T18:25:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/atg7-immunohistochemical-expression-in-malignant-pleural-mesothelioma-a-preliminary-report/ 2021-12-06T22:02:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/malat1-promotes-malignant-pleural-mesothelioma-by-sponging-mir-141-3p/ 2021-12-13T16:35:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/assessment-of-risk-of-hereditary-predisposition-in-patients-with-melanoma-and-or-mesothelioma-and-renal-neoplasia/ 2021-12-13T16:52:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/correlation-between-immune-related-adverse-events-and-therapeutic-effects-of-nivolumab-in-patients-with-malignant-pleural-mesothelioma/ 2021-12-13T17:29:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytological-diagnostic-procedures-in-malignant-mesothelioma/ 2021-12-13T18:06:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/brca-associated-protein-1-bap1-and-mir-31-combination-predicts-outcomes-in-epithelioid-malignant-pleural-mesothelioma/ 2021-12-13T22:10:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-junction-burden-and-antigen-presentation-as-predictors-of-survival-in-mesothelioma-treated-with-immune-checkpoint-inhibitors/ 2022-01-04T17:54:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/egfr-targeted-pemetrexed-therapy-of-malignant-pleural-mesothelioma/ 2022-01-04T17:59:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-forms-a-trimer-with-hmgb1-and-hdac1-that-modulates-gene-x-environment-interaction-with-asbestos/ 2022-01-04T20:30:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-epithelial-to-mesenchymal-transition-emt-in-the-development-and-metastasis-of-malignant-pleural-mesothelioma/ 2022-01-04T21:23:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/lipid-profiling-in-malignant-mesothelioma-reveals-promising-signatures-for-diagnosis-and-prognosis-a-plasma-based-lc-ms-lipidomics-study/ 2022-01-04T21:47:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/radical-extrapleural-pneumonectomy-with-bronchial-fistula-by-pulmonary-function-test-evaluation-technique/ 2022-01-10T16:50:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/downregulation-of-lncrna-pvt1-inhibits-proliferation-and-migration-of-mesothelioma-cells-by-targeting-foxm1/ 2022-01-10T18:00:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/downregulation-of-lncrna-pvt1-inhibits-proliferation-and-migration-of-mesothelioma-cells-by-targeting-foxm1-2/ 2022-01-10T21:26:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-highlights-of-the-15th-international-conference-of-the-international-mesothelioma-interest-group-do-molecular-concepts-challenge-the-traditional-approach-to-pathological-mesothelioma-diagnosis/ 2022-01-11T17:07:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-critical-assessment-of-current-grading-schemes-for-diffuse-pleural-mesothelioma-with-a-proposal-for-a-novel-mesothelioma-weighted-grading-scheme-mwgs/ 2022-01-11T18:25:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-microrna-197-3p-as-a-potential-biomarker-for-asbestos-exposure/ 2022-01-17T16:10:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-the-promise-for-present-and-future-of-malignant-pleural-mesothelioma-mpm-treatment/ 2022-01-17T18:04:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-intraoperative-hypertonic-glucose-solution-administration-on-persistent-air-leak-after-extended-pleurectomy-decortication-for-malignant-pleural-mesothelioma-a-retrospective-case-control-s/ 2022-01-17T20:53:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/quality-of-life-is-not-deteriorated-after-extrapleural-pneumonectomy-vs-extended-pleurectomy-decortication-in-patients-with-malignant-pleural-mesothelioma/ 2022-01-17T21:33:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/aurora-kinase-a-as-a-diagnostic-and-prognostic-marker-of-malignant-mesothelioma/ 2022-01-17T21:41:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-induced-mesothelial-injury-and-carcinogenesis-involvement-of-iron-and-reactive-oxygen-species/ 2022-01-24T16:41:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/epigenetic-immune-remodeling-of-mesothelioma-cells-a-new-strategy-to-improve-the-efficacy-of-immunotherapy/ 2022-01-24T18:10:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-era-for-malignant-pleural-mesothelioma-updates-on-therapeutic-options/ 2022-01-24T20:30:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/ppar%ce%b1-and-ppar%ce%b3-activation-is-associated-with-pleural-mesothelioma-invasion-but-therapeutic-inhibition-is-ineffective/ 2022-01-24T20:41:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-infiltrating-lymphocytes-are-functionally-inactivated-by-cd90-stromal-cells-and-reactivated-by-combined-ibrutinib-and-rapamycin-in-human-pleural-mesothelioma/ 2022-01-24T21:28:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-outcomes-after-lung-sparing-surgery-for-epithelial-mesothelioma/ 2022-01-31T18:09:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/biological-pathways-associated-with-the-development-of-pulmonary-toxicities-in-mesothelioma-patients-treated-with-radical-hemithoracic-radiation-therapy-a-preliminary-study/ 2022-01-31T22:01:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-method-for-malignant-pleural-effusion-distinguishing-malignant-mesothelioma-from-lung-cancer-using-pleural-carcinoembryonic-antigen-and-hyaluronic-acid-levels/ 2022-02-01T19:00:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/relationship-between-exposure-to-ionizing-radiation-and-mesothelioma-risk-a-systematic-review-of-the-scientific-literature-and-meta-analysis/ 2022-02-01T20:45:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-germline-variants-in-dna-repair-genes-may-steer-tailored-treatment/ 2022-02-01T21:00:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/metabolomics-of-a-cell-line-derived-xenograft-model-reveals-circulating-metabolic-signatures-for-malignant-mesothelioma/ 2022-02-07T15:54:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/imaging-in-pleural-mesothelioma-a-review-of-the-15th-international-conference-of-the-international-mesothelioma-interest-group/ 2022-02-07T16:24:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/image-guided-interventional-radiological-delivery-of-chimeric-antigen-receptor-car-t-cells-for-pleural-malignancies-in-a-phase-i-ii-clinical-trial/ 2022-02-07T17:52:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgical-strategy-for-malignant-pleural-mesothelioma-the-superiority-of-pleurectomy-decortication/ 2022-02-07T21:12:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/circplk1-acts-as-a-carcinogenic-driver-to-promote-the-development-of-malignant-pleural-mesothelioma-by-governing-the-mir-1294-hmga1-pathway/ 2022-02-07T21:39:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/sarcopenia-precardial-adipose-tissue-and-high-tumor-volume-as-outcome-predictors-in-surgically-treated-pleural-mesothelioma/ 2022-02-14T18:08:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/elemental-mapping-of-human-malignant-mesothelioma-tissue-samples-using-high-speed-la-icp-tofms-imaging/ 2022-02-14T20:44:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-and-characterization-of-ncc-dmm1-c1-a-novel-patient-derived-cell-line-of-desmoplastic-malignant-pleural-mesothelioma/ 2022-02-14T21:58:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/pcbp2-knockdown-promotes-ferroptosis-in-malignant-mesothelioma/ 2022-02-15T16:11:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/first-line-nivolumab-plus-ipilimumab-versus-chemotherapy-in-patients-with-unresectable-malignant-pleural-mesothelioma-3-year-outcomes-from-checkmate-743/ 2022-02-15T17:57:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/small-vessel-vasculitis-and-dry-gangrene-secondary-to-combined-ctla-4-and-pd-1-blockade-in-malignant-mesothelioma/ 2022-02-21T16:59:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/use-of-an-antagonist-of-hmgb1-in-mice-affected-by-malignant-mesothelioma-a-preliminary-ultrasound-and-optical-imaging-study/ 2022-02-21T17:23:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/analysis-of-early-pleural-fluid-samples-in-patients-with-mesothelioma-a-case-series-exploration-of-morphology-bap1-and-cdkn2a-status-with-implications-for-the-concept-of-mesothelioma-in-situ-in-cyt/ 2022-02-21T18:32:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/cisplatin-chelated-iminodiacetic-acid-conjugated-hyaluronic-acid-nanogels-for-the-treatment-of-malignant-pleural-mesothelioma-in-mice/ 2022-02-21T21:26:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/abemaciclib-in-patients-with-p16ink4a-deficient-mesothelioma-mist2-a-single-arm-open-label-phase-2-trial/ 2022-02-22T17:57:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/dynamic-contrast-enhanced-mri-in-malignant-pleural-mesothelioma-prediction-of-outcome-based-on-dce-mri-measurements-in-patients-undergoing-cytotoxic-chemotherapy/ 2022-02-28T17:13:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-systematic-review-and-meta-analysis-of-trials-assessing-pd-1-pd-l1-immune-checkpoint-inhibitors-activity-in-pre-treated-advanced-stage-malignant-mesothelioma/ 2022-03-01T16:07:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-pleural-fluid-cytology-for-the-diagnosis-of-malignant-pleural-effusion-a-retrospective-cohort-study/ 2022-03-01T17:41:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-experience-of-living-with-mesothelioma-a-meta-ethnographic-review-and-synthesis-of-the-qualitative-literature/ 2022-03-01T21:11:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-impact-of-pleural-effusion-in-patients-with-malignancy-a-systematic-review-and-meta-analysis/ 2022-03-01T21:23:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/salvage-debulking-surgery-and-hyperthermic-intrathoracic-chemotherapy-for-massive-recurrent-mesothelioma-in-the-mediastinum/ 2022-03-07T15:58:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-and-future-treatment-options-in-mesothelioma-a-systematic-review/ 2022-03-08T17:23:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/control-of-air-leakage-during-pleurectomy-decortication-by-the-ventilation-and-anchoring-method/ 2022-03-08T18:37:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-pathways-in-peritoneal-mesothelioma-a-minireview-of-new-insights/ 2022-03-08T21:08:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/ecm-mechanoregulation-in-malignant-pleural-mesothelioma/ 2022-03-08T21:17:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-priorities-of-people-with-mesothelioma-and-their-carers-a-qualitative-interview-study-of-trial-participation-and-treatment-decisions/ 2022-03-14T17:04:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-approaches-for-the-treatment-of-unresectable-malignant-pleural-mesothelioma-a-focus-on-immunotherapy-and-target-therapy-review/ 2022-03-14T19:56:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-3-randomized-clinical-trials-of-frontline-therapies-for-malignant-pleural-mesothelioma/ 2022-03-14T20:06:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-defect-of-amphiregulin-release-predicted-longer-survival-independently-of-yap-expression-in-patients-with-pleural-mesothelioma-in-the-ifct-0701-maps-phase-3-trial/ 2022-03-15T20:49:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/benign-multicystic-peritoneal-mesothelioma-presents-as-a-tumor-in-an-elderly-man-an-uncommon-diagnosis/ 2022-03-15T20:54:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/living-with-mesothelioma-a-systematic-review-of-patient-and-caregiver-psychosocial-support-needs/ 2022-03-21T14:46:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-redox-silent-analogue-of-tocotrienol-may-break-the-homeostasis-of-proteasomes-in-human-malignant-mesothelioma-cells-by-inhibiting-stat3-and-nrf1/ 2022-03-21T16:20:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-update-on-emerging-therapeutic-options-for-malignant-pleural-mesothelioma/ 2022-03-22T15:02:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-value-and-safety-of-thoracoscopic-pleural-biopsies-in-pleural-exudative-effusions-of-unknown-origin-including-follow-up/ 2022-03-22T20:26:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/repeat-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-for-cancers-with-peritoneal-metastasis-a-30-year-institutional-experience/ 2022-03-22T20:39:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/usefulness-of-cyclin-d1-podoplanin-dual-immunohistochemical-stain-to-differentiate-malignant-mesothelioma-from-reactive-mesothelial-proliferations/ 2022-03-28T16:10:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-and-validation-of-a-novel-immune-related-prognostic-signature-in-malignant-pleural-mesothelioma/ 2022-03-28T17:13:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/benign-multicystic-peritoneal-mesothelioma-occurring-in-bilateral-inguinal-canals-metachronously-a-case-report/ 2022-03-28T19:54:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-value-of-18f-fdg-pet-ct-in-malignant-pleural-mesothelioma-a-meta-analysis/ 2022-03-28T20:34:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/radiation-induced-abscopal-effect-in-a-patient-with-malignant-pleural-mesothelioma-on-pembrolizumab/ 2022-03-28T20:35:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/transglutaminase-2-enhances-hepatocyte-growth-factor-signaling-to-drive-the-mesothelioma-cancer-cell-phenotype/ 2022-04-04T16:52:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/well-differentiated-papillary-mesothelioma-of-the-tunica-vaginalis-case-report/ 2022-04-04T17:01:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-impact-of-inflammation-in-malignant-pleural-mesothelioma-a-large-scale-analysis-of-consecutive-patients/ 2022-04-04T20:10:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/force-feeding-malignant-mesothelioma-stem-cell-like-with-exosome-delivered-mir-126-induces-tumour-cell-killing/ 2022-04-04T20:32:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-impact-of-inflammation-in-malignant-pleural-mesothelioma-a-large-scale-analysis-of-consecutive-patients-2/ 2022-04-05T14:57:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/systemic-therapy-for-pre-treated-malignant-mesothelioma-a-systematic-review-meta-analysis-and-network-meta-analysis-of-randomised-controlled-trials/ 2022-04-11T14:40:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/anetumab-ravtansine-versus-vinorelbine-in-patients-with-relapsed-mesothelin-positive-malignant-pleural-mesothelioma-arcs-m-a-randomised-open-label-phase-2-trial/ 2022-04-11T16:03:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/first-line-nivolumab-plus-ipilimumab-versus-chemotherapy-for-the-treatment-of-unresectable-malignant-pleural-mesothelioma-patient-reported-outcomes-in-checkmate-743/ 2022-04-11T18:55:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/pulmonary-asbestos-fiber-burden-is-related-to-patient-survival-in-malignant-pleural-mesothelioma/ 2022-04-11T19:35:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-dna-rna-quality-from-cell-block-of-malignant-mesothelioma-and-lung-adenocarcinoma/ 2022-04-11T20:05:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/sulfated-glycans-recognized-by-s1-monoclonal-antibody-can-serve-as-a-diagnostic-marker-for-malignant-pleural-mesothelioma/ 2022-04-18T14:49:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/nintedanib-and-dasatinib-treatments-induce-protective-autophagy-as-a-potential-resistance-mechanism-in-mpm-cells/ 2022-04-19T14:50:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-expression-of-pea15-is-associated-with-patient-survival-in-malignant-pleural-mesothelioma/ 2022-04-19T15:25:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/retinoic-acid-induces-an-ifn-driven-inflammatory-tumour-microenvironment-sensitizing-to-immune-checkpoint-therapy/ 2022-04-19T17:33:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/predictors-of-survival-among-male-and-female-patients-with-malignant-pleural-mesothelioma-a-random-survival-forest-analysis-of-data-from-the-2000-2017-surveillance-epidemiology-and-end-results-prog/ 2022-04-19T21:20:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/minimally-important-differences-of-eortc-qlq-c30-scales-in-patients-with-lung-cancer-or-malignant-pleural-mesothelioma-interpretation-guidance-derived-from-two-randomized-eortc-trials/ 2022-04-25T14:55:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/multicenter-study-of-diffuse-pleural-mesothelioma-histopathological-and-immunohistochemical-features/ 2022-04-25T15:26:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-benefit-of-lurbinectedin-as-palliative-chemotherapy-in-progressive-malignant-pleural-mesothelioma-mpm-final-efficacy-and-translational-data-of-the-sakk-17-16-study/ 2022-04-25T17:18:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/systemic-treatment-in-patients-with-malignant-pleural-mesothelioma-real-life-experience/ 2022-04-25T20:37:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-and-immunohistochemical-characterization-of-mesothelioma-of-the-tunica-vaginalis/ 2022-04-25T21:08:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/feasibility-of-tumor-treating-fields-with-pemetrexed-and-platinum-based-chemotherapy-for-unresectable-malignant-pleural-mesothelioma-single-center-real-world-data/ 2022-05-02T16:51:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/micro-rna-215-and-375-regulate-thymidylate-synthase-protein-expression-in-pleural-mesothelioma-and-mediate-epithelial-to-mesenchymal-transition/ 2022-05-02T17:14:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/medical-and-surgical-care-of-mesothelioma-patients-and-their-relatives-carrying-germline-bap1-mutations/ 2022-05-02T20:30:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/assessment-protocol-of-mesothelioma-and-relevance-of-sem-eds-analysis-through-a-case-studies-of-legal-medicine-of-brescia-italy/ 2022-05-02T20:37:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-definitive-prognostication-system-for-patients-with-thoracic-malignancies-diagnosed-with-coronavirus-disease-2019-an-update-from-the-teravolt-registry/ 2022-05-02T21:13:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/npm2-in-malignant-peritoneal-mesothelioma-from-basic-tumor-biology-to-clinical-medicine/ 2022-05-09T16:00:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-loss-by-immunohistochemistry-predicts-improved-survival-to-first-line-platinum-pemetrexed-chemotherapy-for-pleural-mesothelioma-patients-a-validation-study/ 2022-05-09T16:19:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-pd-l1-in-patients-with-malignant-peritoneal-mesothelioma-a-pilot-study/ 2022-05-09T20:07:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/ultra-high-drug-loading-improves-nanoparticle-efficacy-against-peritoneal-mesothelioma/ 2022-05-09T20:22:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/downregulation-of-ftl-decreases-proliferation-of-malignant-mesothelioma-cells-by-inducing-g-1-cell-cycle-arrest/ 2022-05-09T20:36:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-of-highly-effective-anti-mesothelin-hyp218-chimeric-antigen-receptor-t-cells-with-increased-tumor-infiltration-and-persistence-for-treating-solid-tumors/ 2022-05-16T16:52:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/dissecting-and-reconstructing-matrix-in-malignant-mesothelioma-through-histocell-histochemistry-gradients-for-clinical-applications/ 2022-05-16T21:20:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/advances-in-drug-treatments-for-mesothelioma/ 2022-05-16T21:25:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-and-claudin-4-but-not-mtap-reliably-distinguish-borderline-and-low-grade-serous-ovarian-tumors-from-peritoneal-mesothelioma/ 2022-05-17T15:42:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/splicing-deregulation-microrna-and-notch-aberrations-fighting-the-three-headed-dog-to-overcome-drug-resistance-in-malignant-mesothelioma/ 2022-05-17T16:27:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/primary-pleural-epithelioid-hemangioendothelioma-an-often-misdiagnosed-rare-tumor/ 2022-05-23T15:59:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/generation-and-expansion-of-primary-malignant-pleural-mesothelioma-tumor-lines/ 2022-05-23T16:13:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/picropodophyllin-inhibits-the-growth-of-pemetrexed-resistant-malignant-pleural-mesothelioma-via-microtubule-inhibition-and-igf-1r-caspase-independent-pathways/ 2022-05-23T16:43:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/multimodal-treatment-of-malignant-pleural-mesothelioma-real-world-experience-with-112-patients/ 2022-05-23T19:27:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/hdac-inhibition-with-valproate-improves-direct-cytotoxicity-of-monocytes-against-mesothelioma-tumor-cells/ 2022-05-23T19:40:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/5-hmc-loss-is-another-useful-tool-in-addition-to-bap1-and-mtap-immunostains-to-distinguish-diffuse-malignant-peritoneal-mesothelioma-from-reactive-mesothelial-hyperplasia-in-peritoneal-cytology-cell-b/ 2022-05-31T17:02:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-canadian-single-centre-experience-with-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-for-abdominal-malignancies/ 2022-05-31T17:11:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/two-year-intermittent-exposure-of-a-multiwalled-carbon-nanotube-by-intratracheal-instillation-induces-lung-tumors-and-pleural-mesotheliomas-in-f344-rats/ 2022-05-31T17:18:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/ezh2-inhibitor-tazemetostat-in-patients-with-relapsed-or-refractory-bap1-inactivated-malignant-pleural-mesothelioma-a-multicentre-open-label-phase-2-study/ 2022-05-31T17:26:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/update-of-pathological-diagnosis-of-pleural-mesothelioma-using-genomic-based-morphological-techniques-for-both-histological-and-cytological-investigations/ 2022-06-06T15:22:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/effects-of-inhalable-gene-transfection-as-a-novel-gene-therapy-for-non-small-cell-lung-cancer-and-malignant-pleural-mesothelioma/ 2022-06-06T16:27:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/headspace-volatile-organic-compound-profiling-of-pleural-mesothelioma-and-lung-cancer-cell-lines-as-translational-bridge-for-breath-research/ 2022-06-06T16:47:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/association-between-thoracic-epidural-block-and-major-complications-after-pleurectomy-decortication-for-malignant-pleural-mesothelioma-under-general-anesthesia/ 2022-06-06T20:46:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelioid-pleural-mesothelioma-is-characterized-by-tertiary-lymphoid-structures-in-long-survivors-results-from-the-match-study/ 2022-06-06T21:09:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-drug-screening-revealed-novel-potential-agents-against-malignant-pleural-mesothelioma/ 2022-06-13T14:25:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-surgery-and-hipec-for-malignant-peritoneal-mesothelioma-outcomes-and-survival-from-an-australian-centre/ 2022-06-13T14:55:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/unexplained-pleural-effusion-leads-to-the-revelation-of-a-malignant-mesothelioma-a-case-report/ 2022-06-13T15:02:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/adenomatoid-mesothelioma-arising-from-the-diaphragm-a-case-report-and-review-of-the-literature/ 2022-06-13T15:24:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/discrimination-of-malignant-pleural-mesothelioma-cell-lines-using-amino-acid-metabolomics-with-hplc/ 2022-06-13T15:57:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/living-beyond-expectations-a-qualitative-study-into-the-experience-of-long-term-survivors-with-pleural-mesothelioma-and-their-carers/ 2022-06-20T15:24:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/lung-cancer-and-mesothelioma-risks-in-a-prospective-cohort-of-workers-with-asbestos-related-lung-or-pleural-diseases/ 2022-06-20T17:21:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/dysregulation-of-micrornas-and-trna-derived-ncrnas-in-mesothelial-and-mesothelioma-cell-lines-after-asbestiform-fiber-exposure/ 2022-06-20T20:14:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/ewsr1yy1-fusion-positive-peritoneal-epithelioid-mesothelioma-harbors-mesothelioma-epigenetic-signature-report-of-3-cases-in-support-of-an-emerging-entity/ 2022-06-20T20:22:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomics-of-tumor-origin-and-characteristics-for-adenocarcinoma-and-malignant-pleural-mesothelioma-a-case-report/ 2022-06-20T20:35:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/nfe2l3-as-a-novel-biomarker-associated-with-il-2-stat5-nlrp3-signaling-pathway-in-malignant-pleural-mesothelioma-and-other-cancers/ 2022-06-27T15:16:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-prognostic-score-for-patients-with-malignant-pleural-mesothelioma-mpm-receiving-second-line-immunotherapy-or-chemotherapy-in-the-etop-9-15-promise-meso-phase-iii-trial/ 2022-06-27T15:23:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-i-study-of-tremelimumab-monotherapy-or-in-combination-with-durvalumab-in-japanese-patients-with-advanced-solid-tumors-or-malignant-mesothelioma/ 2022-06-27T15:33:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/yap1-is-essential-for-malignant-mesothelioma-tumor-maintenance/ 2022-06-27T16:42:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-expression-levels-of-certain-mirnas-in-predicting-diagnosis-prognosis-and-response-to-chemotherapy-in-malignant-pleural-mesothelioma/ 2022-06-27T17:27:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-characterization-of-mesothelioma-impact-of-histologic-type-and-site-of-origin-on-molecular-landscape/ 2022-07-05T17:28:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-health-effects-of-short-fiber-chrysotile-and-amphibole-asbestos/ 2022-07-05T17:50:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/repurposing-therapeutics-for-malignant-pleural-mesothelioma-mpm-updates-on-clinical-translations-and-future-outlook/ 2022-07-05T18:02:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/primary-malignant-pericardial-mesothelioma-with-a-survival-of-2-5-years-a-case-report/ 2022-07-05T20:10:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/active-symptom-control-with-or-without-oral-vinorelbine-in-patients-with-relapsed-malignant-pleural-mesothelioma-vim-a-randomised-phase-2-trial/ 2022-07-11T15:56:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/ten-year-single-center-experience-with-treatment-of-primary-diffuse-malignant-peritoneal-mesothelioma-dmpm-by-cytoreductive-surgery-crs-and-hyperthermic-intraperitoneal-chemotherapy-hipec/ 2022-07-11T16:42:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/intraperitoneal-paclitaxel-for-patients-with-primary-malignant-peritoneal-mesothelioma-a-phase-i-ii-dose-escalation-and-safety-study-interact-meso/ 2022-07-11T19:56:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-combination-of-mtap-and-p16-immunohistochemistry-can-substitute-for-cdkn2a-fluorescence-in-situ-hybridization-in-diagnosis-and-prognosis-of-pleural-mesotheliomas/ 2022-07-11T20:11:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/second-surgery-for-recurrent-malignant-pleural-mesothelioma-after-multimodality-treatment-a-systematic-review/ 2022-07-11T20:25:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/combined-treatment-with-inhibitors-of-erbb-receptors-and-hh-signaling-pathways-is-more-effective-than-single-treatment-in-reducing-the-growth-of-malignant-mesothelioma-both-in-vitro-and-in-vivo/ 2022-07-18T16:49:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/rapid-diagnosis-of-malignant-pleural-mesothelioma-and-its-discrimination-from-lung-cancer-and-benign-exudative-effusions-using-blood-serum/ 2022-07-18T20:06:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-factors-of-malignant-peritoneal-mesothelioma-a-retrospective-study-of-52-female-patients/ 2022-07-18T21:42:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-approaches-for-malignant-pleural-mesothelioma/ 2022-07-18T21:49:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-comprehensive-study-of-alternative-splicing-in-malignant-pleural-mesothelioma-identifies-potential-therapeutic-targets-in-a-new-cluster-with-poor-survival/ 2022-07-19T17:25:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/challenges-and-limitation-of-mtap-immunohistochemistry-in-diagnosing-desmoplastic-mesothelioma-sarcomatoid-pleural-mesothelioma-with-desmoplastic-features/ 2022-07-25T17:09:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/thrombocytopenia-as-an-immune-related-adverse-event-in-malignant-pleural-mesothelioma-a-case-report/ 2022-07-25T17:14:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-role-of-tumor-immune-microenvironment-in-pleural-epithelioid-mesothelioma/ 2022-07-26T13:53:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/substance-gp-2250-as-a-new-therapeutic-agent-for-malignant-peritoneal-mesothelioma-a-3-d-in-vitro-study/ 2022-07-26T15:26:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-values-of-preoperative-c-reactive-protein-albumin-and-neutrophil-ratios-in-patients-with-malignant-pleural-mesothelioma-who-underwent-extrapleural-pneumonectomy/ 2022-07-26T16:47:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-alterations-in-malignant-pleural-mesothelioma-a-hope-for-effective-treatment-by-targeting-yap/ 2022-08-01T15:04:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/does-mediastinal-lymph-node-involvement-influence-the-surgical-outcome-in-malign-pleural-mesothelioma/ 2022-08-01T16:58:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-significance-of-9p21-gene-combined-with-bap1-and-mtap-protein-expression-in-diagnosis-and-prognosis-of-mesothelioma-serous-effusion/ 2022-08-01T17:05:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/organic-extract-of-geodia-cydonium-induces-cell-cycle-block-in-human-mesothelioma-cells/ 2022-08-01T19:35:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/lurbinectedin-shows-clinical-activity-and-immune-modulatory-functions-in-patients-with-pre-treated-small-cell-lung-cancer-and-malignant-pleural-mesothelioma/ 2022-08-01T19:50:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-nodules-remodel-their-surroundings-to-vascularize-and-grow/ 2022-08-08T16:23:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-and-adverse-events-of-apatinib-salvage-treatment-for-refractory-diffuse-malignant-peritoneal-mesothelioma-a-pilot-study/ 2022-08-08T17:32:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-potential-antigens-for-developing-mrna-vaccine-for-immunologically-cold-mesothelioma/ 2022-08-08T17:51:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/sera-from-patients-with-malignant-pleural-mesothelioma-tested-positive-for-igg-antibodies-against-sv40-large-t-antigen-the-viral-oncoprotein/ 2022-08-08T20:22:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/curcuminoids-as-modulators-of-emt-in-invasive-cancers-a-review-of-molecular-targets-with-the-contribution-of-malignant-mesothelioma-studies/ 2022-08-08T20:32:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/silencing-vdac1-to-treat-mesothelioma-cancer-tumor-reprograming-and-altering-tumor-hallmarks/ 2022-08-15T16:02:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-alterations-in-malignant-pleural-mesothelioma-a-hope-for-effective-treatment-by-targeting-yap-2/ 2022-08-15T16:47:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/possible-therapeutic-utility-of-anti-cell-adhesion-molecule-1-antibodies-for-malignant-pleural-mesothelioma/ 2022-08-15T19:49:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/repurposing-clofazimine-for-malignant-pleural-mesothelioma-treatment-in-vitro-assessment-of-efficacy-and-mechanism-of-action/ 2022-08-15T20:03:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/kap1-is-a-new-non-genetic-vulnerability-of-malignant-pleural-mesothelioma-mpm/ 2022-08-16T15:56:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/kap1-is-a-new-non-genetic-vulnerability-of-malignant-pleural-mesothelioma-mpm-2/ 2022-08-22T16:35:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-suppressor-effect-of-an-antibody-on-xenotransplanted-sarcomatoid-mesothelioma-cells/ 2022-08-22T20:14:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/classification-and-detection-of-mesothelioma-cancer-using-feature-selection-enabled-machine-learning-technique/ 2022-08-22T20:37:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/cost-effectiveness-of-nivolumab-plus-ipilimumab-as-first-line-treatment-for-american-patients-with-unresectable-malignant-pleural-mesothelioma/ 2022-08-23T16:40:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-capacity-of-bap1-and-mtap-in-cytology-from-effusions-and-biopsy-in-mesothelioma/ 2022-08-23T17:04:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/single-center-20-year-experience-in-surgical-treatment-of-malignant-pleural-mesothelioma/ 2022-08-29T17:09:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-examination-of-the-anti-cancer-properties-of-plant-cannabinoids-in-preclinical-models-of-mesothelioma/ 2022-08-29T19:54:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/chemoresistance-related-to-hypoxia-adaptation-in-mesothelioma-cells-from-tumor-spheroids/ 2022-08-29T20:27:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/artichoke-phytocomplex-modulates-serum-micrornas-in-patients-exposed-to-asbestos-a-first-step-of-a-phase-ii-clinical-trial/ 2022-08-29T20:45:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/fdg-pet-ct-for-staging-and-restaging-malignant-mesothelioma/ 2022-08-29T20:45:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/activation-of-adaptive-and-innate-immune-cells-via-localized-interleukin-2-cytokine-factories-eradicates-mesothelioma-tumors/ 2022-09-06T16:05:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/case-report-mesothelioma-and-bap1-tumor-predisposition-syndrome-implications-for-public-health/ 2022-09-06T17:11:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-combination-of-intrinsic-and-extrinsic-features-improves-prognostic-prediction-in-malignant-pleural-mesothelioma/ 2022-09-06T17:18:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-detector-position-and-light-fluence-distribution-using-an-infrared-navigation-system-during-pleural-photodynamic-therapy/ 2022-09-06T17:28:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/hypothesis-heg1-and-claudin-4-staining-will-allow-a-diagnosis-of-epithelioid-and-biphasic-mesothelioma-versus-non-small-cell-lung-carcinoma-with-only-two-stains-in-most-cases/ 2022-09-12T15:28:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-primary-malignant-pericardial-mesothelioma-with-myocardial-involvement-a-comprehensive-assessment-using-multimodel-echocardiography/ 2022-09-12T16:53:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/training-and-validation-of-a-knowledge-based-dose-volume-histogram-predictive-model-in-the-optimisation-of-intensity-modulated-proton-and-volumetric-modulated-arc-photon-plans-for-pleural-mesothelioma/ 2022-09-12T19:43:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/microbiomes-epigenomics-immune-response-and-splicing-signatures-interplay-potential-use-of-combination-of-regulatory-pathways-as-targets-for-malignant-mesothelioma/ 2022-09-12T19:48:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/pso-based-evolutionary-approach-to-optimize-head-and-neck-biomedical-image-to-detect-mesothelioma-cancer/ 2022-09-12T19:57:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-risk-assessment-model-for-alternative-splicing-events-and-splicing-factors-in-malignant-pleural-mesothelioma/ 2022-09-19T15:21:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-presenting-with-high-protein-high-serum-ascites-albumin-gradient/ 2022-09-19T15:40:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/il-7-is-expressed-in-malignant-mesothelioma-and-has-a-prognostic-value/ 2022-09-19T16:22:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/feasibility-and-safety-of-extended-pleurectomy-decortication-for-malignant-pleural-mesothelioma-a-single-group-experience/ 2022-09-19T16:52:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-trial-of-intra-pleural-bacterial-immunotherapy-in-malignant-pleural-mesothelioma-tilt-a-randomised-feasibility-study-using-the-trial-within-a-cohort-twic-methodology/ 2022-09-19T17:03:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/meta-analysis-of-survival-after-extrapleural-pneumonectomy-epp-versus-pleurectomy-decortication-p-d-for-malignant-pleural-mesothelioma-in-the-context-of-macroscopic-complete-resection-mcr/ 2022-09-26T17:20:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/survival-effect-of-complete-multimodal-therapy-in-malignant-pleural-mesothelioma/ 2022-09-26T19:40:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/brief-report-multimodality-therapy-in-patients-with-primary-pericardial-mesothelioma/ 2022-09-26T19:55:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/proposal-for-a-new-local-recurrence-score-in-patients-with-recurrent-malignant-pleural-mesothelioma/ 2022-09-27T19:50:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/kras-pathway-alterations-in-malignant-pleural-mesothelioma-an-underestimated-player/ 2022-09-27T20:02:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-treatment-algorithms-of-the-swiss-peritoneal-cancer-group-for-peritoneal-cancer-of-gastrointestinal-origin/ 2022-10-03T17:57:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/er-stress-response-and-induction-of-apoptosis-in-malignant-pleural-mesothelioma-the-achilles-heel-targeted-by-the-anticancer-ruthenium-drug-bold-100/ 2022-10-03T19:31:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/bmp-and-activin-membrane-bound-inhibitor-regulate-connective-tissue-growth-factor-controlling-mesothelioma-cell-proliferation/ 2022-10-03T19:45:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/combination-of-pd-1-pd-l1-checkpoint-inhibition-and-dendritic-cell-therapy-in-mice-models-and-in-patients-with-mesothelioma/ 2022-10-04T18:13:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/effects-of-tumor-infiltrating-cd8-t-cells-pd1-pd-l1-axis-and-expression-patterns-of-hla-class-i-on-the-prognosis-of-patients-with-malignant-pleural-mesothelioma-who-underwent-extra-pleural-pneumone/ 2022-10-04T18:23:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-phosphorylated-ribosomal-protein-s6-in-mesothelioma-patients-correlation-with-clinico-pathological-characteristics-and-outcome-results-from-the-european-thoracic-oncology-platform-et/ 2022-10-10T17:26:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/immune-cells-in-mesothelioma-microenvironment-simplistic-marker-of-response-to-nivolumab-plus-ipilimumab/ 2022-10-10T17:47:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-landscape-of-pleural-and-peritoneal-mesothelioma-tumours/ 2022-10-10T17:52:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-surgical-treatment-of-pleural-mesothelioma-in-a-porcine-model-using-magnetic-resonance-guided-focused-ultrasound-surgery-mrgfus-and-radiofrequency-ablation-rfa/ 2022-10-10T20:11:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/systematic-review-meta-analysis-and-bioinformatic-analysis-of-biomarkers-for-prognosis-of-malignant-pleural-mesothelioma/ 2022-10-10T20:21:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/incidence-and-risk-factors-of-chest-wall-metastasis-at-biopsy-sites-in-patients-with-malignant-pleural-mesothelioma/ 2022-10-24T13:52:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/define-the-two-molecular-subtypes-of-epithelioid-malignant-pleural-mesothelioma/ 2022-10-24T13:58:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-combined-with-antiangiogenic-agents-in-patients-with-advanced-malignant-pleural-mesothelioma-a-case-report/ 2022-10-24T14:05:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/desmoid-type-fibromatosis-in-the-setting-of-malignant-peritoneal-mesothelioma-a-case-report-of-two-rare-diseases/ 2022-10-24T14:14:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/investigation-of-pd-l1-cd274-pd-l2-pdcd1lg2-and-ctla-4-expressions-in-malignant-pleural-mesothelioma-by-immunohistochemistry-and-real-time-polymerase-chain-reaction-methods/ 2022-10-24T16:25:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/butein-instigated-mir-186-5p-dependent-modulation-of-twist1-affects-resistance-to-cisplatin-and-bioenergetics-of-malignant-pleural-mesothelioma-cells/ 2022-11-14T15:56:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-candidates-in-the-differential-diagnosis-of-malignant-mesothelioma-from-benign-mesothelial-hyperplasia-and-adenocarcinoma-dars2-and-suprabasin/ 2022-11-14T16:31:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/factors-affecting-the-life-expectancy-in-malignant-pleural-mesothelioma-our-10-years-of-studies-and-experience/ 2022-11-14T17:05:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/analysis-of-the-correlation-between-zeste-enhancer-homolog-2-ezh2-mrna-expression-and-the-prognosis-of-mesothelioma-patients-and-immune-infiltration/ 2022-11-14T18:18:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/emerging-role-of-immunomonitoring-to-predict-the-clinical-outcome-of-patients-with-malignant-pleural-mesothelioma-treated-with-radical-radiation-therapy/ 2022-11-14T18:38:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/journey-to-the-centre-of-the-lung-the-perspective-of-a-mineralogist-on-the-carcinogenic-effects-of-mineral-fibres-in-the-lungs/ 2022-11-28T18:04:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-survival-by-multimodal-treatment-regimen-among-malignant-pleural-mesothelioma-patients-in-an-integrated-health-system/ 2022-11-28T18:18:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-ability-and-its-influenced-factors-of-ultrasound-guided-percutaneous-pleural-needle-biopsy-diagnosis-for-malignant-pleural-mesothelioma/ 2022-11-28T20:55:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/assessment-of-mir-103a-3p-in-leukocytes-no-diagnostic-benefit-in-combination-with-the-blood-based-biomarkers-mesothelin-and-calretinin-for-malignant-pleural-mesothelioma-diagnosis/ 2022-11-28T21:09:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/heterogeneous-rna-editing-and-influence-of-adar2-on-mesothelioma-chemoresistance-and-the-tumor-microenvironment/ 2022-11-28T21:11:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/final-results-of-diadem-a-phase-ii-study-to-investigate-the-efficacy-and-safety-of-durvalumab-in-advanced-pretreated-malignant-pleural-mesothelioma/ 2022-12-05T22:41:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-outcomes-and-risk-factors-of-residual-thoracic-spaces-after-pleurectomy-decortication-for-mesothelioma/ 2022-12-05T22:58:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/utility-of-berep4-calretinin-and-desmin-epithelial-membrane-antigen-ema-dual-immunocytochemical-staining-in-effusion-cytology/ 2022-12-05T23:25:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytological-diagnosis-of-malignant-mesothelioma-a-case-series/ 2022-12-06T20:58:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/loss-of-npm2-expression-is-a-potential-immunohistochemical-marker-for-malignant-peritoneal-mesothelioma-a-single-center-study-of-92-cases/ 2022-12-06T21:29:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/extracellular-vesicles-isolated-from-malignant-mesothelioma-cancer-associated-fibroblasts-induce-pro-oncogenic-changes-in-healthy-mesothelial-cells/ 2022-12-12T21:36:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/blood-cell-dna-methylation-biomarkers-in-preclinical-malignant-pleural-mesothelioma-the-epic-prospective-cohort/ 2022-12-12T21:42:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/disturbance-of-the-warburg-effect-by-dichloroacetate-and-niclosamide-suppresses-the-growth-of-different-sub-types-of-malignant-pleural-mesothelioma-in-vitro-and-in-vivo/ 2022-12-12T21:49:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-extracellular-matrix-protein-fibulin-3-efemp1-promotes-pleural-mesothelioma-growth-by-activation-of-pi3k-akt-signaling/ 2022-12-12T21:53:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/conditional-survival-following-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-for-peritoneal-surface-malignancies-an-analysis-from-the-us-hipec-collaborative/ 2022-12-12T22:23:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/rhoa-and-vigilin-are-candidates-for-immunohistochemical-markers-for-epithelioid-malignant-mesothelioma/ 2022-12-19T20:00:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/smg6-regulates-dna-damage-and-cell-survival-in-hippo-pathway-kinase-lats2-inactivated-malignant-mesothelioma/ 2022-12-19T20:04:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-features-shown-by-fdg-pet-ct/ 2022-12-19T20:11:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/coronary-artery-stenosis-caused-by-primary-malignant-pericardial-mesothelioma-in-a-76-year-old-man/ 2022-12-19T21:54:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/rate-advancement-measurement-for-lung-cancer-and-pleural-mesothelioma-in-asbestos-exposed-workers/ 2022-12-19T22:13:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-pleural-thickness-on-occurrence-of-postoperative-complications-in-patients-with-malignant-pleural-mesothelioma/ 2023-01-03T21:27:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/protocol-for-a-prospective-observational-cohort-study-collecting-data-on-demographics-symptoms-and-biomarkers-in-people-with-mesothelioma-assess-meso/ 2023-01-03T21:00:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/inflammation-as-a-chemoprevention-target-in-asbestos-induced-malignant-mesothelioma/ 2023-01-03T21:07:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/multifactorial-evaluation-following-cytoreductive-surgery-for-malignant-pleural-mesothelioma-in-patients-with-high-symptom-burden/ 2023-01-03T21:13:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunostimulatory-oncolytic-activity-of-coxsackievirus-a11-in-human-malignant-pleural-mesothelioma/ 2023-01-03T21:20:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/anti-mesothelin-immunotoxin-induces-mesothelioma-eradication-anti-tumor-immunity-and-the-development-of-tertiary-lymphoid-structures/ 2023-01-09T15:55:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/histopathological-and-immunohistochemical-features-of-14-peritoneal-mesotheliomas-with-clinical-outcomes-and-recent-updates/ 2023-01-09T17:05:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-effects-of-preserving-the-diaphragm-on-early-and-late-outcome-of-lung-sparing-radical-surgery-for-malignant-pleural-mesothelioma/ 2023-01-09T21:12:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/isolated-bap1-genomic-alteration-in-malignant-pleural-mesothelioma-predicts-distinct-immunogenicity-with-implications-for-immunotherapeutic-response/ 2023-01-09T21:23:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/usefulness-of-nf2-hemizygous-loss-detected-by-fluorescence-in-situ-hybridization-in-diagnosing-pleural-mesothelioma-in-tissue-and-cytology-material-a-multi-institutional-study/ 2023-01-09T21:48:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/preclinical-evaluation-of-cdk4-phosphorylation-predicts-high-sensitivity-of-pleural-mesotheliomas-to-cdk4-6-inhibition/ 2023-01-16T18:34:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/final-results-of-diadem-a-phase-ii-study-to-investigate-the-efficacy-and-safety-of-durvalumab-in-advanced-pretreated-malignant-pleural-mesothelioma-2/ 2023-01-16T18:56:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-ii-window-of-opportunity-study-of-neoadjuvant-pd-l1-versus-pd-l1-plus-ctla-4-blockade-for-patients-with-malignant-pleural-mesothelioma/ 2023-01-16T19:07:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-sting-agonist-dmxaa-reduces-tumor-vessels-and-enhances-mesothelioma-tumor-antigen-presentation-yet-blunts-cytotoxic-t-cell-function-in-a-murine-model/ 2023-01-16T21:02:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-a-new-potential-plasmatic-biomarker-panel-for-the-diagnosis-of-malignant-pleural-mesothelioma/ 2023-01-16T21:18:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/extensive-peritonectomy-is-an-independent-risk-factor-for-cisplatin-hipec-induced-acute-kidney-injury/ 2023-01-23T18:20:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/potential-roles-of-exosomes-in-the-development-and-detection-of-malignant-mesothelioma-an-update/ 2023-01-23T18:37:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/cdk4-6-inhibition-enhances-the-efficacy-of-standard-chemotherapy-treatment-in-malignant-pleural-mesothelioma-cells/ 2023-01-23T18:47:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/multimodal-therapy-of-epithelioid-pleural-mesothelioma-improved-survival-by-changing-the-surgical-treatment-approach/ 2023-01-23T21:12:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/diverse-and-divergent-functions-of-il-32%ce%b2-and-il-32%ce%b3-isoforms-in-the-regulation-of-malignant-pleural-mesothelioma-cell-growth-and-the-production-of-vegf-a-and-cxcl8/ 2023-01-23T21:22:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/nr4a3-fusions-characterize-a-distinctive-peritoneal-mesothelial-neoplasm-of-uncertain-biological-potential-with-pure-adenomatoid-microcystic-morphology/ 2023-01-30T18:20:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-glycolysis-genes-signature-for-predicting-prognosis-in-malignant-pleural-mesothelioma-by-bioinformatics-and-machine-learning/ 2023-01-30T18:26:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/brca1-haploinsufficiency-impairs-iron-metabolism-to-promote-chrysotile-induced-mesothelioma-via-ferroptosis-resistance/ 2023-01-30T18:37:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-loss-induces-mitotic-defects-in-mesothelioma-cells-through-brca1-dependent-and-independent-mechanisms/ 2023-01-30T20:47:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-cancer-cells-are-glutamine-addicted-and-glutamine-restriction-reduces-yap1-signaling-to-attenuate-tumor-formation/ 2023-01-30T21:12:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/axl-and-met-tyrosine-kinase-receptors-co-expression-as-a-potential-therapeutic-target-in-malignant-pleural-mesothelioma/ 2023-02-06T17:01:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-efficacy-and-safety-of-nivolumab-in-malignant-non-pleural-mesothelioma-a-multicenter-open-label-single-arm-japanese-phase-ii-trial-viola-protocol/ 2023-02-06T18:33:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-1-safety-study-of-avelumab-plus-stereotactic-body-radiation-therapy-in-malignant-pleural-mesothelioma/ 2023-02-06T18:56:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/tislelizumab-combined-with-anlotinib-in-the-second-line-treatment-of-malignant-pleural-mesothelioma/ 2023-02-07T18:11:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-and-safety-of-nivolumab-with-ipilimumab-for-recurrent-malignant-pleural-mesothelioma-after-primary-surgical-intervention/ 2023-02-07T20:59:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-extracellular-vesicle-derived-micrornas-as-potential-biomarkers-for-pleural-mesothelioma-in-a-european-prospective-study%ef%bf%bc/ 2023-02-13T14:41:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/thiolate-dnazymes-on-gold-nanoparticles-for-isothermal-amplification-and-detection-of-mesothelioma-derived-exosomal-pd-l1-mrna/ 2023-02-13T18:40:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/well-differentiated-papillary-mesothelial-tumour-of-the-tunica-vaginalis-testis-a-rare-lesion-but-one-pathologists-should-know-about-two-patient-reports-and-a-review-of-the-literature/ 2023-02-13T21:06:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/carbon-ion-beam-irradiation-in-combination-with-cisplatin-effectively-suppresses-xenografted-malignant-pleural-mesothelioma/ 2023-02-13T21:16:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-ph-sensitive-theranostic-plga-nanoparticle-for-boron-neutron-capture-therapy-in-mesothelioma-treatment/ 2023-02-13T21:37:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/unusually-aggressive-presentation-of-malignant-peritoneal-mesothelioma-two-case-reports/ 2023-02-20T15:19:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-diagnostic-markers-for-malignant-pleural-mesothelioma-a-narrative-review/ 2023-02-20T16:13:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/genetic-screens-reveal-new-targetable-vulnerabilities-in-bap1-deficient-mesothelioma/ 2023-02-20T16:20:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/psychosocial-well-being-among-patients-with-malignant-pleural-mesothelioma/ 2023-02-20T16:52:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-instability-and-pro-tumoral-inflammation-are-associated-with-primary-resistance-to-anti-pd1-anti-angiogenesis-in-malignant-pleural-mesothelioma/ 2023-02-20T17:00:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunohistochemistry-for-claudin-4-and-bap1-in-the-differential-diagnosis-between-sarcomatoid-carcinoma-and-sarcomatoid-mesothelioma/ 2023-02-27T16:18:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-associated-fibroblasts-enhance-proliferation-and-migration-of-pleural-mesothelioma-cells-via-c-met-pi3k-and-wnt-signaling-but-do-not-protect-against-cisplatin/ 2023-02-27T17:37:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-cytologic-diagnosis-of-mesothelioma-are-we-there-yet/ 2023-02-27T17:50:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-molecular-phenotypic-map-of-malignant-pleural-mesothelioma/ 2023-02-27T18:04:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/correlation-of-serum-soluble-mesothelin-related-protein-hmgb1-and-ca125-in-diffuse-malignant-peritoneal-mesothelioma-and-their-combined-measurement-for-prognosis/ 2023-02-27T18:10:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-predictive-value-of-ercc1-rrm1-and-thymidylate-synthase-in-advanced-malignant-pleural-mesothelioma-patients-treated-with-platinum-based-chemotherapy/ 2023-03-06T15:35:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/mir-142-3p-suppresses-invasion-and-adhesion-of-mesothelioma-cells-by-downregulating-itgav/ 2023-03-06T16:16:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/micro-fragmented-fat-inhibits-the-progression-of-human-mesothelioma-xenografts-in-mice/ 2023-03-06T16:47:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-thickness-in-mesothelioma-predicts-differential-response-to-neoadjuvant-therapy-and-survival/ 2023-03-06T16:58:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/importance-of-histopathological-grading-for-treatment-selection-in-malignant-mesothelioma/ 2023-03-06T17:07:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleurectomy-and-decortication-are-associated-with-better-survival-for-bicavitary-cytoreductive-surgery-for-mesothelioma-compared-with-extrapleural-pneumonectomy/ 2023-03-13T16:19:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-survival-in-patients-treated-with-cytoreduction-and-heated-intraperitoneal-chemotherapy-for-peritoneal-mesothelioma-at-a-single-high-volume-center/ 2023-03-13T16:31:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/cd70-and-pd-l1-cd274-co-expression-predicts-poor-clinical-outcomes-in-patients-with-pleural-mesothelioma/ 2023-03-13T16:37:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/mek1-drives-oncogenic-signaling-and-interacts-with-parp1-for-genomic-and-metabolic-homeostasis-in-malignant-pleural-mesothelioma/ 2023-03-13T16:46:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-and-transcriptomic-analyses-identify-a-prognostic-gene-signature-and-predict-response-to-therapy-in-pleural-and-peritoneal-mesothelioma/ 2023-03-13T16:58:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/add-on-effect-of-hemagglutinating-virus-of-japan-envelope-combined-with-chemotherapy-or-immune-checkpoint-inhibitor-against-malignant-pleural-mesothelioma-an-in-vivo-study/ 2023-03-20T14:50:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-highly-sensitive-pleural-effusion-protein-biomarkers-for-malignant-pleural-mesothelioma-by-affinity-based-quantitative-proteomics/ 2023-03-20T15:11:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/medical-application-of-the-monoclonal-antibody-skm9-2-against-sialylated-heg1-a-new-precision-marker-for-malignant-mesothelioma/ 2023-03-20T15:52:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/neurofibromatosis-type-2-yes-associated-protein-and-transcriptional-coactivator-with-pdz-binding-motif-dual-immunohistochemistry-is-a-reliable-marker-for-the-detection-of-neurofibromatosis-type-2-alte/ 2023-03-20T15:59:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/defining-and-targeting-tumor-associated-macrophages-in-malignant-mesothelioma/ 2023-03-20T16:07:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-due-to-workplace-exposure-a-comprehensive-bibliometric-analysis-of-current-situation-and-future-trends/ 2023-03-27T16:47:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-preliminary-toxicity-results-of-adjuvant-radiotherapy-hypofractionation-in-a-prospective-trial-meso-rt/ 2023-03-27T16:52:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/small-rna-seq-transcriptome-profiling-of-mesothelial-and-mesothelioma-cell-lines-revealed-microrna-dysregulation-after-exposure-to-asbestos-like-fibers/ 2023-03-27T16:57:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-prognostic-nomogram-for-predicting-survival-in-diffuse-pleural-mesothelioma/ 2023-03-27T17:03:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/validity-of-diagnoses-of-respiratory-diseases-recorded-in-a-japanese-administrative-database/ 2023-03-27T17:12:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-therapeutic-approaches-for-pleural-mesothelioma-identified-by-functional-ex-vivo-drug-sensitivity-testing/ 2023-04-03T16:35:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-in-situ-mimicking-well-differentiated-papillary-mesothelial-tumor/ 2023-04-03T16:40:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/benign-multicystic-peritoneal-mesothelioma-mimicking-mucinous-ovarian-neoplasm-with-pseudomyxoma-peritonei/ 2023-04-03T16:44:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-survival-of-more-than-5-years-with-maintenance-therapy-using-single-agent-pemetrexed-in-a-patient-with-diffuse-malignant-peritoneal-mesothelioma/ 2023-04-03T16:54:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-evolving-role-of-immune-checkpoint-inhibitors-in-malignant-pleural-mesothelioma/ 2023-04-03T16:59:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-value-of-emt-gene-signature-in-malignant-mesothelioma/ 2023-04-10T16:16:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/benefits-and-challenges-of-inhibiting-ezh2-in-malignant-pleural-mesothelioma/ 2023-04-10T16:26:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/effects-of-pharmacological-primary-cilium-disturbance-in-the-context-of-in-vitro-2d-and-3d-malignant-pleura-mesothelioma/ 2023-04-10T16:41:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/trop2-expression-and-sn38-antitumor-activity-in-malignant-pleural-mesothelioma-cells-provide-a-rationale-for-antibody-drug-conjugate-therapy/ 2023-04-10T16:46:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-in-malignant-peritoneal-mesothelioma-review/ 2023-04-10T16:52:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/epidemiological-therapeutic-and-survival-trends-in-malignant-pleural-mesothelioma-a-review-of-the-national-cancer-database/ 2023-04-17T16:46:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-narrative-review-management-of-malignant-pleural-effusion-related-to-malignant-pleural-mesothelioma/ 2023-04-17T16:51:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-rare-case-of-primary-gastric-burkitts-lymphoma-associated-with-malignant-pleural-mesothelioma/ 2023-04-17T16:58:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-characteristics-and-outcomes-a-seer-medicare-analysis/ 2023-04-17T17:11:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/primary-cardiac-mesothelioma-presenting-with-fulminant-recurrent-pericarditis-a-case-report/ 2023-04-17T17:19:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-pathogenic-germline-variants-identified-in-mesothelioma/ 2023-04-24T16:43:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-cytological-features-of-effusions-with-mesothelioma-in-situ-a-report-of-9-cases/ 2023-04-24T16:56:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-robotic-future-of-minimally-invasive-cytoreduction-and-hyperthermic-intraperitoneal-chemotherapy-for-peritoneal-surface-malignancies/ 2023-04-24T17:00:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/disparities-in-survival-due-to-social-determinants-of-health-and-access-to-treatment-in-us-patients-with-operable-malignant-pleural-mesothelioma/ 2023-04-24T17:07:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/developing-sustainable-patient-and-public-involvement-in-mesothelioma-research-multi-method-exploration-with-researchers-patients-carers-and-patient-organisations/ 2023-04-24T17:12:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/ultrasensitive-dose-response-for-asbestos-cancer-risk-implied-by-new-inflammation-mutation-model/ 2023-05-01T18:39:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/surface-modified-inhaled-microparticle-encapsulated-celastrol-for-enhanced-efficacy-in-malignant-pleural-mesothelioma/ 2023-05-01T18:44:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/intratumor-microbiota-as-a-novel-potential-prognostic-indicator-in-mesothelioma/ 2023-05-01T18:50:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-role-for-macrophages-under-cytokine-control-in-mediating-resistance-to-adi-peg20-pegargiminase-in-ass1-deficient-mesothelioma/ 2023-05-01T19:02:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/association-of-mesothelioma-deaths-with-neighborhood-asbestos-exposure-due-to-a-large-scale-asbestos-cement-plant/ 2023-05-01T19:09:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/three-distinct-mechanisms-underlying-human-%ce%b3%ce%b4-t-cell-mediated-cytotoxicity-against-malignant-pleural-mesothelioma/ 2023-05-08T14:22:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgical-case-report-the-rare-case-of-incidental-retroperitoneal-mesothelioma/ 2023-05-08T20:23:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-study-of-somatic-brca-variants-and-their-putative-effect-on-protein-properties-in-malignant-mesothelioma/ 2023-05-08T20:30:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/genetic-analysis-of-familial-predisposition-in-the-pathogenesis-of-malignant-pleural-mesothelioma/ 2023-05-08T20:34:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/excess-of-blood-eosinophils-prior-to-therapy-correlates-with-worse-prognosis-in-mesothelioma/ 2023-05-08T20:40:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-of-an-experimental-model-of-canine-malignant-mesothelioma-organoid-culture-using-a-three-dimensional-culture-method/ 2023-05-15T13:29:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/damage-associated-molecular-patterns-and-sensing-receptors-based-molecular-subtypes-in-malignant-pleural-mesothelioma-and-implications-for-immunotherapy/ 2023-05-15T13:40:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-mesothelin-expression-by-immunohistochemistry-predicts-improved-survival-in-pleural-mesothelioma/ 2023-05-15T14:08:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgical-phenotype-of-patients-with-peritoneal-mesothelioma-and-a-germline-mutation/ 2023-05-15T15:49:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-vs-chemotherapy-in-subsequent-treatment-of-malignant-pleural-mesothelioma-which-is-better/ 2023-05-15T15:57:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-selective-aldh1a3-inhibitor-impairs-mesothelioma-3-d-multicellular-spheroid-growth-and-neutrophil-recruitment/ 2023-05-22T13:29:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/one-third-of-malignant-pleural-mesothelioma-shows-high-immunohistochemical-expression-of-msln-or-cxcr4-which-indicates-potent-candidates-for-endo-radiotherapy/ 2023-05-22T13:42:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/kras-mutations-are-associated-with-shortened-survival-in-patients-with-epithelioid-malignant-pleural-mesothelioma/ 2023-05-22T13:47:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/epidemiological-therapeutic-and-survival-trends-in-malignant-pleural-mesothelioma-a-review-of-the-national-cancer-database-2/ 2023-05-22T13:56:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-iii-study-of-pemetrexed-in-combination-with-cisplatin-versus-cisplatin-alone-in-patients-with-malignant-pleural-mesothelioma/ 2023-05-22T14:39:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/antitumoral-effects-of-bortezomib-in-malignant-mesothelioma-evidence-of-mild-endoplasmic-reticulum-stress-in-vitro-and-activation-of-t-cell-response-in-vivo/ 2023-05-22T15:16:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-epithelial-biomarker-analysis-of-malignant-mesothelioma-epcam-positivity-is-a-potential-diagnostic-pitfall/ 2023-05-30T16:03:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/individualized-prediction-of-survival-benefit-from-postoperative-radiotherapy-for-patients-with-malignant-pleural-mesothelioma/ 2023-05-30T16:22:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/epigenetic-investigation-into-circulating-microrna-197-3p-in-sera-from-patients-affected-by-malignant-pleural-mesothelioma-and-workers-ex-exposed-to-asbestos/ 2023-05-30T16:31:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/concurrent-induction-of-apoptosis-and-necroptosis-in-apigenin%e2%80%91treated-malignant-mesothelioma-cells-reversal-of-warburg-effect-through-akt-inhibition-and-p53-upregulation/ 2023-05-30T16:41:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-significance-of-inflammation-related-and-electrolyte-laboratory-variables-in-patients-with-malignant-pleural-mesothelioma/ 2023-06-05T14:22:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/atg5-as-biomarker-for-early-detection-of-malignant-mesothelioma/ 2023-06-05T14:28:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-the-role-of-18-f-fluorodeoxyglucose-pet-computed-tomography-and-68-ga-labeled-fap-inhibitor-04-pet-ct-in-patients-with-malignant-mesothelioma/ 2023-06-05T14:35:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-isoform-dtx3c-associates-with-ube2n-uba1-and-cdc48-p97-as-part-of-the-ephb4-degradation-complex-regulated-by-the-autocrine-igf-ii-ira-signal-in-malignant-mesothelioma/ 2023-06-05T14:48:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/lncrnas-and-related-molecular-basis-in-malignant-pleural-mesothelioma-challenges-and-potential/ 2023-06-05T14:54:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/sequential-multi-parametric-mri-in-assessment-of-the-histological-subtype-and-features-in-the-malignant-pleural-mesothelioma-xenografts/ 2023-06-12T14:27:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/reliability-of-assessing-morphologic-features-with-prognostic-significance-in-cytology-specimens-of-epithelioid-diffuse-pleural-mesothelioma-and-implications-for-cytopathology-reporting/ 2023-06-12T14:48:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-expression-of-smo-and-gli1-genes-with-poor-prognosis-in-malignant-mesothelioma/ 2023-06-12T14:59:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/geldanamycin-treatment-does-not-result-in-anti-cancer-activity-in-a-preclinical-model-of-orthotopic-mesothelioma/ 2023-06-12T15:21:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-significance-of-the-immuno-peritoneal-cancer-index-in-peritoneal-metastatic-patients-treated-with-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy/ 2023-06-12T15:30:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-role-of-cd74-cd10-and-ki-67-immunohistochemical-expression-in-patients-with-diffuse-malignant-peritoneal-mesothelioma-a-retrospective-study/ 2023-06-19T14:55:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/combination-therapy-with-anti-programmed-cell-death-1-antibody-plus-angiokinase-inhibitor-exerts-synergistic-antitumor-effect-against-malignant-mesothelioma-via-tumor-microenvironment-modulation/ 2023-06-19T15:33:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/metabolic-effects-of-new-glucose-transporter-glut-1-and-lactate-dehydrogenase-a-ldh-a-inhibitors-against-chemoresistant-malignant-mesothelioma/ 2023-06-19T16:05:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-two-gene-expression-based-prognostic-score-in-malignant-pleural-mesothelioma/ 2023-06-19T16:10:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-clinicopathological-significance-of-top2a-expression-in-malignant-peritoneal-mesothelioma/ 2023-06-19T16:16:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/european-epidemiology-of-pleural-mesothelioma-real-life-data-from-a-joint-analysis-of-the-mesoscape-database-of-the-european-thoracic-oncology-platform-and-the-european-society-of-thoracic-surgery-m/ 2023-06-26T14:30:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunohistochemical-expression-of-camp-in-fluoroedenite%e2%80%91induced-malignant-pleural-mesothelioma-preliminary-results/ 2023-06-26T14:52:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/matrigel-based-organoid-culture-of-malignant-mesothelioma-reproduces-cisplatin-sensitivity-through-ctr1/ 2023-06-26T15:10:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-density-and-proximity-of-cd8-t-cells-to-tumor-cells-are-correlated-with-better-response-to-nivolumab-treatment-in-metastatic-pleural-mesothelioma/ 2023-06-26T15:35:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-markers-for-management-of-mesothelioma/ 2023-07-03T14:42:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-surgery-crs-and-heated-intraperitoneal-chemotherapy-hipec-for-peritoneal-mesothelioma-canadian-practices-and-outcomes/ 2023-07-03T14:56:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinically-occult-diffuse-pleural-mesothelioma-in-patients-presenting-with-spontaneous-pneumothorax/ 2023-07-03T15:03:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-axl-in-mesothelioma-from-functional-characterization-to-clinical-implication/ 2023-07-03T15:11:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/la-icp-ms-analysis-reveals-differences-in-chemotherapeutic-drug-distribution-in-surgically-resected-pleural-mesothelioma/ 2023-07-03T15:42:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/dynamics-and-survival-associations-of-t-cell-receptor-clusters-in-patients-with-pleural-mesothelioma-treated-with-immunotherapy/ 2023-07-10T14:49:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-video-assisted-pleurectomy-decortication-surgery-plus-hyperthermic-intrathoracic-chemotherapy-with-vats-talc-pleurodesis-for-the-treatment-of-malignant-pleural-mesothelioma-a-pilot-stud/ 2023-07-10T15:07:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-mitochondrial-antioxidant-defense-and-cdk4-6-in-mesothelioma/ 2023-07-10T15:32:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/target-therapy-in-malignant-pleural-mesothelioma-hope-or-mirage/ 2023-07-10T18:33:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/indolyl-chalcone-derivatives-trigger-apoptosis-in-cisplatin-resistant-mesothelioma-cells-through-aberrant-tubulin-polymerization-and-deregulation-of-microtubule-associated-proteins/ 2023-07-10T18:55:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/pressurized-intraperitoneal-aerosol-chemotherapy-reasons-for-interrupting-treatment-a-systematic-review-of-the-literature/ 2023-07-17T15:20:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/intrapleural-anticancer-therapy-for-malignant-pleural-diseases-facts-or-fiction/ 2023-07-17T15:31:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/traditional-treatment-approaches-and-role-of-immunotherapy-in-lung-malignancy-and-mesothelioma/ 2023-07-17T15:46:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/complement-protein-c1q-stimulates-hyaluronic-acid-degradation-via-gc1qr-habp1-p32-in-malignant-pleural-mesothelioma/ 2023-07-17T16:04:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-immunohistochemical-mesothelial-biomarkers-in-paired-biopsies-and-effusion-cytology-cell-blocks-from-pleural-mesothelioma/ 2023-07-17T16:13:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-fgf18-is-decreased-in-pleural-mesothelioma-but-not-correlated-with-disease-prognosis/ 2023-07-24T14:13:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-of-a-bayesian-network-model-to-predict-the-survival-of-malignant-peritoneal-mesothelioma-patients-after-cytoreductive-surgery-plus-hyperthermic-intraperitoneal-chemotherapy/ 2023-07-24T15:22:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/genes-and-pathways-involved-in-the-progression-of-malignant-pleural-mesothelioma-a-meta-analysis-of-genome-wide-expression-studies/ 2023-07-24T15:45:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/spc212-human-mesothelioma-cells-underwent-apoptosis-oxidative-stress-and-morphological-deformation-following-astaxanthin-treatment/ 2023-07-24T15:51:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-risk-peritoneal-mesothelioma-does-metronomic-chemotherapy-have-a-role/ 2023-07-24T16:05:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-rare-presentation-of-malignant-mesothelioma-of-the-tunica-vaginalis-managed-with-immunotherapy-and-review-of-the-literature/ 2023-07-31T14:41:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/synchronous-pleural-and-peritoneal-mesothelioma-a-case-report-and-narrative-review/ 2023-07-31T15:10:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-risk-peritoneal-mesothelioma-does-metronomic-chemotherapy-have-a-role-2/ 2023-07-31T15:18:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/setdb1-tumour-suppressor-roles-in-near-haploid-mesothelioma-involve-tp53/ 2023-07-31T15:24:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/multi-institutional-patterns-of-use-of-tumor-treating-fields-for-patients-with-malignant-pleural-mesothelioma/ 2023-07-31T15:51:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/ramucirumab-plus-erlotinib-versus-placebo-plus-erlotinib-in-previously-untreated-egfr-mutated-metastatic-non-small-cell-lung-cancer-relay-exploratory-analysis-of-next-generation-sequencing-results/ 2023-08-07T16:30:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/vegfr2-and-cd34-expression-associated-with-longer-survival-in-patients-with-pleural-mesothelioma-in-the-ifct-gfpc-0701-maps-phase-3-trial/ 2023-08-07T18:09:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/genetic-pathways-in-peritoneal-mesothelioma-tumorigenesis/ 2023-08-07T18:31:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesenchymal-stromal-cells-loaded-with-paclitaxel-paclimes-a-potential-new-therapeutic-approach-on-mesothelioma/ 2023-08-07T19:40:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/progranulin-and-egfr-modulate-receptor-like-tyrosine-kinase-sorting-and-stability-in-mesothelioma-cells/ 2023-08-07T20:23:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-of-a-prognostic-nomogram-for-patients-with-malignant-mesothelioma-with-bone-metastasis/ 2023-08-14T17:14:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-anoikis-based-gene-signature-for-predicting-prognosis-in-malignant-pleural-mesothelioma-and-revealing-immune-infiltration/ 2023-08-14T17:21:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/gene-fusions-during-the-early-evolution-of-mesothelioma-correlate-with-impaired-dna-repair-and-hippo-pathways/ 2023-08-14T17:29:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/management-of-sarcomatoid-malignant-pleural-mesothelioma-brain-metastases-with-stereotactic-radiosurgery-an-illustrative-case/ 2023-08-14T17:34:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/peritoneal-papillary-mesothelioma-in-situ-bap1-mutation-with-indolent-behavior-for-15-years/ 2023-08-14T17:41:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/adjuvant-dendritic-cell-based-immunotherapy-after-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-in-patients-with-malignant-peritoneal-mesothelioma-a-phase-ii-clinical-trial/ 2023-08-21T16:36:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-mpm-presenting-as-hydropneumothorax/ 2023-08-21T17:44:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-accelerates-disease-onset-in-a-genetic-model-of-malignant-pleural-mesothelioma/ 2023-08-21T19:30:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-alterations-and-potential-actionable-mutations-in-peritoneal-mesothelioma-a-scoping-review-of-high-throughput-sequencing-studies/ 2023-08-21T19:59:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/spatially-resolved-high-dimensional-transcriptomics-sorts-out-the-evolution-of-biphasic-malignant-pleural-mesothelioma-new-paradigms-for-immunotherapy/ 2023-08-21T20:14:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-cells-with-characteristic-intracytoplasmic-vacuolization-and-lipids/ 2023-08-28T18:07:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/cisplatin-exhibits-superiority-over-mmc-as-a-perfusion-agent-in-a-peritoneal-mesothelioma-patient-specific-organoid-hipec-platform/ 2023-08-28T20:22:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-stathmin-in-asbestos-like-fibers-induced-mesothelioma-a-preliminary-report/ 2023-08-28T20:33:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/leptospermum-extract-qv0-suppresses-pleural-mesothelioma-tumor-growth-in-vitro-and-in-vivo-by-mitochondrial-dysfunction-associated-apoptosis/ 2023-08-28T20:54:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/2022-psogi-consensus-on-hipec-regimens-for-peritoneal-malignancies-diffuse-malignant-peritoneal-mesothelioma/ 2023-08-28T21:04:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/camk2d-a-novel-molecular-target-for-bap1-deficient-malignant-mesothelioma/ 2023-09-05T14:22:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-evidence-and-future-perspectives-about-the-role-of-parp-inhibitors-in-the-treatment-of-thoracic-cancers/ 2023-09-05T14:27:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-in-the-era-of-immunotherapy/ 2023-09-05T15:44:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/predicting-survival-for-patients-with-mesothelioma-development-of-the-place-prognostic-model/ 2023-09-05T16:05:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-tils-and-patterns-of-gene-expression-from-paired-samples-of-malignant-pleural-mesothelioma-mpm-patients/ 2023-09-11T16:31:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/omics-overview-of-the-sparc-gene-in-mesothelioma/ 2023-09-11T16:36:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/pathological-classification-of-malignant-peritoneal-mesothelioma-and-comparative-analysis-with-peritoneal-carcinomatosis/ 2023-09-11T16:42:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/longitudinal-monitoring-of-response-to-chemotherapy-in-patients-with-malignant-pleural-mesothelioma-by-biomarkers/ 2023-09-11T16:49:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyperthermic-intrathoracic-extracorporeal-chemotherapy-for-secondary-malignant-pleural-disease/ 2023-09-11T16:55:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/germline-variants-incidentally-detected-via-tumor-only-genomic-profiling-of-patients-with-mesothelioma/ 2023-09-18T16:58:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/cost-effectiveness-and-budget-impact-of-nivolumab-plus-ipilimumab-versus-platinum-plus-pemetrexed-with-and-without-bevacizumab-in-patients-with-unresectable-malignant-pleural-mesothelioma-in-switzer/ 2023-09-18T17:07:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/cancer-associated-fibroblasts-influence-survival-in-pleural-mesothelioma-digital-gene-expression-analysis-and-supervised-machine-learning-model/ 2023-09-18T17:15:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/predicting-overall-survival-for-patients-with-malignant-mesothelioma-following-radiotherapy-via-interpretable-machine-learning/ 2023-09-18T17:26:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/does-hyperthermic-povidone-iodine-lavage-increase-the-apoptotic-rate-of-residual-cancer-cell-in-patients-with-malignant-pleural-mesothelioma-a-prospective-pilot-study/ 2023-09-18T17:55:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/strategies-to-reduce-morbidity-following-pleurectomy-and-decortication-for-malignant-pleural-mesothelioma/ 2023-09-25T15:04:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/zimberelimab-plus-chemotherapy-as-the-first-line-treatment-of-malignant-peritoneal-mesothelioma-a-case-report-and-review-of-literature/ 2023-09-25T15:26:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/ape-1-ref-1-inhibition-blocks-malignant-pleural-mesothelioma-cell-proliferation-and-migration-crosstalk-between-oxidative-stress-and-epithelial-mesenchymal-transition-emt-in-driving-carcinogenesis/ 2023-09-25T16:34:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/chronic-inflammation-oxidative-stress-and-metabolic-plasticity-three-players-driving-the-pro-tumorigenic-microenvironment-in-malignant-mesothelioma/ 2023-09-25T20:27:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/jsi-124-inhibits-cell-proliferation-and-tumor-growth-by-inducing-autophagy-and-apoptosis-in-murine-malignant-mesothelioma/ 2023-09-25T20:36:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/foxm1-promotes-mesothelioma-cell-migration-and-invasion-via-activation-of-smad-signaling/ 2023-10-02T14:15:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognosis-prediction-of-patients-with-malignant-pleural-mesothelioma-using-conditional-variational-autoencoder-on-3d-pet-images-and-clinical-data/ 2023-10-02T14:24:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/extrathoracic-metastases-in-pleural-mesothelioma/ 2023-10-02T14:32:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-subtyping-via-sampling-driven-multiple-instance-prediction-on-tissue-image-and-cell-morphology-data/ 2023-10-02T14:37:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelioid-mesothelioma-patients-with-very-long-survival-display-defects-in-dna-repair/ 2023-10-02T15:48:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/cullin-4b-ubiquitin-ligase-is-important-for-cell-survival-and-regulates-tgf-%ce%b21-expression-in-pleural-mesothelioma/ 2023-10-09T15:02:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/determining-the-clinical-utility-of-a-breath-test-for-screening-an-asbestos-exposed-population-for-pleural-mesothelioma-baseline-results/ 2023-10-09T15:18:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/induction-of-metallothionein-expression-by-supplementation-of-zinc-induces-resistance-against-platinum-based-treatment-in-malignant-pleural-mesothelioma/ 2023-10-09T15:24:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-dose-iv-magnesium-in-mesothelioma-patients-receiving-surgery-with-hyperthermic-intraoperative-cisplatin-pilot-studies-and-design-of-a-phase-ii-randomized-clinical-trial/ 2023-10-09T15:32:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/krebs-von-den-lungen-6-kl-6-is-a-novel-diagnostic-and-prognostic-biomarker-in-pleural-mesothelioma/ 2023-10-09T15:39:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/melodic-maestros-unraveling-the-role-of-mirnas-in-the-diagnosis-progression-and-drug-resistance-of-malignant-pleural-mesothelioma/ 2023-10-16T14:55:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/brain-metastases-with-malignant-peritoneal-mesothelioma-never-reported-before/ 2023-10-16T15:38:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-yb-1-via-entinostat-enhances-cisplatin-sensitivity-of-pleural-mesothelioma-in-vitro-and-in-vivo/ 2023-10-16T16:00:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/hmgb1-released-by-mesothelial-cells-drives-the-development-of-asbestos-induced-mesothelioma/ 2023-10-16T17:01:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-fluid-to-blood-bnp-ratio-may-contribute-to-prognosis-in-malignant-pleural-mesothelioma/ 2023-10-16T17:47:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-fluid-to-blood-bnp-ratio-may-contribute-to-prognosis-in-malignant-pleural-mesothelioma-2/ 2023-11-07T17:41:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-irreversible-tead-inhibitor-swtx-143-blocks-hippo-pathway-transcriptional-output-and-causes-tumor-regression-in-preclinical-mesothelioma-models/ 2023-11-07T18:21:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-immunohistochemical-markers-for-pleural-mesothelioma-subtyping/ 2023-11-07T18:50:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/uroplakin-iiib-as-a-novel-immunohistochemical-marker-for-mesothelioma/ 2023-11-07T19:04:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/uroplakin-iiib-as-a-novel-immunohistochemical-marker-for-mesothelioma-2/ 2023-11-07T21:15:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/uroplakin-iiib-as-a-novel-immunohistochemical-marker-for-mesothelioma-3/ 2023-11-13T19:04:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/gelatinous-pleural-effusion-a-diagnostic-challenge-for-pleural-mesothelioma-in-an-80-year-old-man/ 2023-11-13T19:14:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/effects-of-combined-therapeutic-targeting-of-axl-and-atr-on-pleural-mesothelioma-cells/ 2023-11-13T19:27:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-bioinformatics-analysis-of-the-role-of-vwf-in-the-tumor-microenvironment-of-malignant-mesothelioma/ 2023-11-13T19:35:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/claudin-4-immunocytochemistry-is-specific-and-sensitive-for-the-diagnosis-of-malignant-carcinomatous-effusions-results-from-a-pilot-study/ 2023-11-13T19:51:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/functional-enhancement-of-mesothelin-targeted-truc-t-cells-by-a-pd1-cd28-chimeric-switch-receptor/ 2023-11-28T19:59:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/perioperative-discordance-in-mesothelioma-cell-type-after-pleurectomy-decortication-a-possible-detrimental-effect-of-neoadjuvant-chemotherapy-due-to-epithelial-to-mesenchymal-transition/ 2023-11-28T20:31:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/quality-of-life-in-patients-with-picc-diagnosed-with-mesothelioma-results-of-a-multicenter-epidemiological-survey-lifepicc/ 2023-11-28T20:54:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/preventive-and-therapeutic-opportunities-targeting-bap1-and-or-hmgb1-pathways-to-diminish-the-burden-of-mesothelioma/ 2023-11-28T21:00:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/pd-1-expressing-macrophages-and-cd8-t-cells-are-independent-predictors-of-clinical-benefit-from-pd-1-inhibition-in-advanced-mesothelioma/ 2023-11-28T22:53:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-prognostic-value-of-f18-fluorothymidine-positron-emission-tomography-for-assessing-the-response-of-malignant-pleural-mesothelioma-to-chemotherapy-a-prospective-cohort-study/ 2023-12-04T20:39:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/deletions-of-cdkn2a-and-mtap-detected-by-copy-number-variation-array-are-associated-with-loss-of-p16-and-mtap-protein-in-pleural-mesothelioma/ 2023-12-04T20:58:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/mth1-inhibition-alleviates-immune-suppression-and-enhances-the-efficacy-of-anti-pd-l1-immunotherapy-in-experimental-mesothelioma/ 2023-12-04T21:02:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-a-snapshot-of-emerging-drug-targets-and-opportunities-for-non-surgical-therapeutic-advancement/ 2023-12-04T21:06:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/contribution-of-bap1-loss-and-p16-cdkn2a-deletion-analysis-to-the-definitive-diagnosis-of-mesothelioma-in-effusion-cytology/ 2023-12-04T21:12:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/co-existing-pericardial-and-pleural-malignant-mesothelioma-responding-well-to-nedaplatin-and-pemetrexed-a-case-report/ 2023-12-12T20:22:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-of-mesothelioma-specific-oncolytic-immunotherapy-enabled-by-immunopeptidomics-of-murine-and-human-mesothelioma-tumors/ 2023-12-12T20:00:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-of-the-testes-with-retroperitoneal-recurrence-and-resection-in-an-80-year-old-male-and-review-of-the-literature/ 2023-12-12T20:06:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-single-nucleotide-polymorphisms-related-to-iron-homeostasis-in-mesothelioma-susceptibility-after-asbestos-exposure-a-genetic-study-on-autoptic-samples/ 2023-12-12T20:15:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-perioperative-systemic-chemotherapy-on-survival-for-patients-who-have-diffuse-malignant-peritoneal-mesothelioma-treated-with-crs-hipec/ 2023-12-12T20:29:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/crosstalk-with-lung-fibroblasts-shapes-the-growth-and-therapeutic-response-of-mesothelioma-cells/ 2023-12-19T17:53:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-data-mining-technique-for-detecting-malignant-mesothelioma-cancer-using-multiple-regression-analysis/ 2023-12-19T17:58:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-immunological-landscape-of-m1-and-m2-macrophages-and-their-spatial-distribution-in-patients-with-malignant-pleural-mesothelioma/ 2023-12-19T18:08:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-with-tumor-treating-fields-ttfields-suppresses-intercellular-tunneling-nanotube-formation-in-vitro-and-upregulates-immuno-oncologic-biomarkers-in-vivo-in-malignant-mesothelioma/ 2023-12-19T18:20:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-deep-learning-based-model-deepmpm-to-help-predict-survival-in-patients-with-malignant-pleural-mesothelioma/ 2023-12-19T18:27:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/salvage-pleurectomy-decortication-following-immunotherapy-for-malignant-pleural-mesothelioma/ 2024-01-02T17:27:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/deciphering-signaling-pathway-interplay-via-mirnas-in-malignant-pleural-mesothelioma/ 2024-01-02T18:19:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-survival-analysis-of-pleural-mesothelioma-patients-undergoing-surgery-brief-report-from-a-tertiary-referral-centre/ 2024-01-02T18:27:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/safety-and-efficacy-of-helical-tomotherapy-following-lung-sparing-surgery-in-locally-advanced-malignant-pleural-mesothelioma/ 2024-01-02T21:49:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-interplay-between-the-immune-system-tumor-suppressor-genes-and-immune-senescence-in-mesothelioma-development-and-response-to-immunotherapy/ 2024-01-02T22:02:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-advances-in-blood-and-pleural-biomarkers/ 2024-01-08T18:11:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-profiling-of-tissue-and-blood-predicts-survival-outcomes-in-patients-with-resected-pleural-mesothelioma/ 2024-01-08T20:11:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/formalin-fixed-paraffin-embedded-proteomics-of-malignant-mesothelioma-and-new-candidate-biomarkers-thioredoxin-and-superoxide-dismutase-2-for-immunohistochemistry/ 2024-01-08T20:24:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/brief-report-real-world-toxicity-and-survival-of-combination-immunotherapy-in-pleural-mesothelioma-riomeso/ 2024-01-08T21:03:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/randomized-trial-of-intravenous-versus-bidirectional-chemotherapy-after-cytoreductive-surgery-for-malignant-peritoneal-mesothelioma/ 2024-01-08T21:17:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-2-trial-of-nivolumab-and-ramucirumab-for-relapsed-mesothelioma-hcrn-lun15-299/ 2024-01-15T18:15:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/case-report-early-diagnosis-and-bevacizumab-based-chemotherapy-for-primary-pericardial-mesothelioma-a-case-with-occupational-asbestos-exposure-history/ 2024-01-15T18:40:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/combined-inhibition-of-ezh2-and-fgfr-is-synergistic-in-bap1-deficient-malignant-mesothelioma/ 2024-01-15T20:33:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/lag3-is-an-independent-prognostic-biomarker-and-potential-target-for-immune-checkpoint-inhibitors-in-malignant-pleural-mesothelioma-a-retrospective-study/ 2024-01-15T21:03:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/analysis-of-ki67-protein-expression-and-clinicopathological-features-in-patients-with-peritoneal-mesothelioma/ 2024-01-16T20:06:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-staging-and-radiological-response-criteria-in-patients-treated-with-immune-checkpoint-inhibitors/ 2024-01-22T18:27:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/validation-of-a-gene-expression-approach-for-the-cytological-diagnosis-of-epithelioid-and-biphasic-pleural-mesothelioma-on-a-consecutive-series/ 2024-01-22T19:56:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/enhancing-the-efficacy-of-vaccinia-based-oncolytic-virotherapy-by-inhibiting-cxcr2-mediated-mdsc-trafficking/ 2024-01-22T20:15:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/anti-pd1-does-not-improve-pyroptosis-induced-by-%ce%b3%ce%b4-t-cells-but-promotes-tumor-regression-in-a-pleural-mesothelioma-mouse-model/ 2024-01-22T20:57:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/methylthioadenosine-phosphorylase-and-breast-cancer-1-protein-associated-protein-1-as-biomarkers-for-the-peritoneal-mesothelioma/ 2024-01-22T21:44:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-hyperthermic-intrathoracic-chemotherapy-hithoc-during-resection-of-pleural-mesothelioma-on-patient-survival/ 2024-01-29T17:44:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-value-of-computed-tomography-and-magnetic-resonance-imaging-in-ovarian-malignant-mesothelioma/ 2024-01-29T18:59:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-outcomes-of-stereotactic-body-radiation-therapy-for-malignant-pleural-mesothelioma/ 2024-01-29T21:08:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/pd-l1-expression-complements-calgb-prognostic-scoring-system-in-malignant-pleural-mesothelioma/ 2024-01-29T21:20:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/niraparib-plus-dostarlimab-in-pleural-mesothelioma-or-non-small-cell-lung-cancer-harboring-hrr-mutations-interim-results-of-the-unito-001-phase-2-prospective-trial/ 2024-01-29T22:02:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparative-assessment-and-high-throughput-drug-combination-profiling-of-tead-palmitoylation-inhibitors-in-hippo-pathway-deficient-mesothelioma/ 2024-02-05T18:07:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/antipodoplanin-antibody-enhances-the-antitumor-effects-of-ctla-4-blockade-against-malignant-mesothelioma-by-natural-killer-cells/ 2024-02-05T18:30:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/extensive-skeletal-muscle-metastases-in-malignant-pleural-mesothelioma-detected-by-fdg-pet-ct/ 2024-02-05T20:50:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/reflecting-real-world-patients-with-mesothelioma-in-research-an-interim-report-of-baseline-characteristics-from-the-assess-meso-cohort/ 2024-02-05T20:58:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/testicular-paratesticular-mesothelial-tumours-uncommon-histopathologic-entities-in-a-very-complex-anatomical-site/ 2024-02-05T21:17:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-immunohistochemistry-next-generation-sequencing-and-fluorescence-in-situ-hybridization-for-detection-of-mtap-loss-in-pleural-mesothelioma/ 2024-02-12T17:40:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-and-immunohistochemical-testing-in-mesothelioma-and-other-mesothelial-lesions/ 2024-02-12T18:07:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/extended-pleurectomy-decortication-and-hyperthermic-intraoperative-intrapleural-cisplatin-perfusion-for-malignant-pleural-mesothelioma/ 2024-02-12T21:39:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-chimeric-antigen-receptor-expressing-t-cells-targeting-the-malignant-mesothelioma-specific-antigen-sialylated-heg1/ 2024-02-13T20:30:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/single-cell-transcriptomic-analysis-of-human-pleura-reveals-stromal-heterogeneity-and-informs-in-vitro-models-of-mesothelioma/ 2024-02-13T21:14:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-epithelioid-mesothelioma-of-the-tunica-vaginalis-testis-presenting-as-hydrocele-in-a-kidney-transplant-recipient/ 2024-02-19T17:35:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-knockdown-of-stathmin-with-si-rna-inhibits-invasion-of-mesothelioma/ 2024-02-19T20:00:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/investigation-of-mtap-and-bap1-staining-loss-and-p16-cdkn2a-deletion-in-pleural-cytology-specimens-and-its-role-in-the-diagnosis-of-mesothelioma/ 2024-02-19T20:31:30+00:00 monthly 0.2